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Summary 
Peripheral blood mononuclear cells (PBMCs) are the only source of human lymphoid cells routinely 
available for immunologic research and for immunomonitoring of T-cell responses to microbial and 
tumor-associated antigens. However the large majority of human T-cells resides in tissues, especially in 
lymphatic organs, while only 1 % of the body’s T-cells circulate in the blood stream. Previous work in 
mice and humans had indicated that CD4 T-cells transiently lose antigen sensitivity when cellular 
contacts are lost, e.g. by leaving lymphoid organs such as lymph nodes (LNs) and entering the 
circulation. In this study, these findings were extended to CD8 T-cells. Thus, CD8 T-cell responses of 
the human tonsil show a significant drop in sensitivity to viral antigens if tissue-exit was simulated by 
keeping cells in dispersed culture at body temperature for two hours.  
Conversely, tissue-like functionality in blood-derived CD8 T-cells was restored by applying the simple 
and robust RESTORE protocol. Indeed, application of the RESTORE protocol, i.e. pre-culturing 
PBMCs for two days at a high cell density before initiation of antigenic stimulation, demonstrated that 
CD8 T-cell responses to a broad range of viral and to tumor-associated antigens are greatly 
underestimated, and sometimes even remain undetected if conventional, unprocessed PBMC cultures 
are used. The latter finding is particularly striking with regard to the appearance of Wilms tumor 1 
(WT1)-specific CD8 T-cell responses in leukemia patients after allogeneic bone marrow 
transplantation. My studies on the mechanism of the RESTORE protocol show that HD preculture of 
PBMCs does not involve antigen-or cytokine-driven clonal expansion of T-cells. Moreover, the gain in 
antigen sensitivity cannot be explained by a decreased activity of regulatory T-cells during the 
preculture step.  The increased antigen sensitivity of CD8 T-cells from HD precultures of PBMCs is 
associated with tonic T-cell receptor signaling as indicated by enhanced tyrosine phosphorylation of 
the CD3 ζ chains and the tyrosine kinase Lck, thereby preparing T-cells for full responses. The 
upregulation of genes involved in aerobic glycolysis in “restored” CD8 memory T-cells relative to fresh 
cells might be an essential requirement for increased T-cell functionality including the regulation of 
IFN-γ production. Taken together, the RESTORE protocol, which was initially described for the CD4 
T-cell response to the antibody TGN1412 permits a more meaningful monitoring of CD8 T-cell 
responses to viral infections and tumors. Furthermore, when generating T-cell lines for adoptive T-cell 
therapy, the RESTORE protocol allows the generation of CD8 T-cell lines with an improved 
representation of clones responding to low antigen concentrations.  
Zusammenfassung 
Mononukleäre Zellen des peripheren Blutes (PBMCs: peripheral blood mononuclear cells) stellen die 
einzige routinemäßig zugängliche Quelle für humane Lymphozyten dar, welche für die 
immunologische Forschung und das „Immunomonitoring“ von T-Zellantworten gegen mikrobielle 
und Tumor-assoziierte Antigene verwendet werden. Jedoch befindet sich der Großteil der T-Zellen 
des Menschen in Geweben, insbesondere den lymphatischen Organen, wohingegen sich nur 1 % der 
T-Zellen im Blut aufhalten. Frühere Studien, die sowohl mit murinen als auch mit humanen Zellen 
durchgeführt wurden, zeigten, dass CD4 T-Zellen ihre Sensitivität gegenüber Antigenen zeitweise 
verlieren sobald zelluläre Kontakte unterbrochen werden. Dies erfolgt beispielsweise beim Verlassen 
der T-Zellen von Geweben und dem Eintreten in die Blutzirkulation. In dieser Arbeit wurden diese 
Beobachtungen auf CD8 T-Zellen ausgeweitet. So weisen humane tonsilläre CD8 T-Zellen eine 
signifikant niedrigere Sensitivität gegenüber viralen Antigenen auf, wenn diese in Dispersion bei 
Körpertemperatur für zwei Stunden gehalten werden, um das Verlassen von Geweben und somit den 
Verlust von zellulären Kontakten zu simulieren.  
Im Gegenzug konnte eine gewebeähnliche T-Zellfunktionalität bei Blutzellen durch Anwendung des 
RESTORE Protokolls wiederhergestellt werden. In der Tat zeigte die Anwendung des RESTORE 
Protokolls, welches eine Vorkultur von PBMCs für zwei Tage bei hoher Zelldichte vor 
antigenspezifischer T-Zellstimulation einschließt, dass CD8 T-Zellantworten gegen eine Vielzahl 
viraler und Tumor-assoziierter Antigene deutlich unterschätzt werden, wenn herkömmliche 
Stimulationsansätze verwendet werden. Teilweise können diese so gemessenen T-Zellantworten bei 
Verwendung herkömmliche Stimulationsansätze auch gar nicht nachgewiesen werden. Dieser Effekt 
war bei der Detektion von Wilms Tumor 1 (WT1)-spezifischen CD8 T-Zellantworten bei 
Leukämiepatienten nach allogener Stammzelltransplantation besonders deutlich zu beobachten. Meine 
mechanistischen Studien zeigten, dass die Vorkultur von PBMCs bei hoher Zelldichte selbst nicht zu 
einer Antigen- oder Zytokin-getriebenen T-Zell Expansion führt. Des Weiteren wurde gezeigt, dass 
der RESTORE Effekt durch den Zugewinn an CD8 T-Zellsensitivität erklärt werden kann und nicht 
auf eine verringerte CD8 T-Zellsuppression durch regulatorische T-Zellen während der Vorkultur 
zurückzuführen ist.  Die erhöhte Antigensensitivität von vorkultivierten CD8 T-Zellen steht im 
Zusammenhang mit tonischer T-Zell Signalweiterleitung, welche anhand von erhöhter Tyrosin 
Phosphorylierung der CD3 ζ Ketten des T-Zell-Rezeptors und der Tyrosinkinase Lck nachgewiesen 
werden kann. Diese tonischen T-Zellsignale bereiten CD8 T-Zellen darauf vor, bereits auf kleine 
Mengen Antigen effektiv zu reagieren. Auch die Hochregulierung von Genen, welche der aeroben 
Glykolyse zuzuordnen sind in vorkultivierten CD8 Gedächtniszellen im Vergleich zu CD8 
Gedächtniszellen, welche direkt aus dem Blut isoliert wurden, trägt zu einer erhöhten T-
Zellfunktionalität bei, welche die Regulation der IFN-γ Produktion einschließt. Zusammenfassend lässt 
sich sagen, dass die Anwendung des RESTORE Protokolls, welches ursprünglich zum Nachweis von 
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CD4 T-Zellantworten gegen den Antikörper TGN1412 entwickelt wurde, eine verlässliche Methode 
zum Nachweis von CD8 T-Zellantworten gegen virale Infektionen und Tumore darstellt. Des 
Weiteren kann das RESTORE Protokoll zur Generierung von T-Zelllinien in der adoptive T-
Zelltherapie eingesetzt werden. Die Anwendung des Protokolls erlaubt das Generieren von Zelllinien, 
welche auch T-Zellklone beinhalten, die durch Immunantworten auf geringe Antigenkonzentrationen 
entstanden sind.  
 
1 Introduction 
1.1 Human T-cells – key players of the adaptive immune 
system 
1.1.1 Innate and adaptive immunity 
The human immune system mediates the body’s defense against pathogenic microbes, such as viruses, 
and against transformed body cells. It can be classified into the innate and the adaptive immune 
system. Innate immunity constitutes the first line of host defense during infection and therefore plays a 
crucial role in the early recognition and subsequent triggering of a proinflammatory response to 
invading pathogens. It consists of (a) cellular and chemical barriers such as skin, mucosal epithelia and 
antimicrobial molecules, (b) blood proteins such as complement, and (c) cells such as phagocytes and 
natural killer cells. The mechanisms of innate immunity rely on a large family of pattern recognition 
receptors (PRRs), which detect distinct evolutionarily conserved structures on pathogens, termed 
pathogen-associated molecular patterns (PAMPs) (Reviewed by (Mogensen 2009)).  
The adaptive immune system, on the other hand, is responsible for the elimination of pathogens in the 
late phase of infection. It is characterized by its highly specific receptors, which are generated by clonal 
gene rearrangements and form a broad repertoire of antigen-specific receptors on bone marrow- (B) or 
thymus- (T) derived lymphocytes (Reviewed by (Litman, Rast et al. 2010)). Antigens are any structural 
substances which serve as a target for the antigen receptor of lymphocytes regardless of whether they 
do or do not  stimulate immune responses (Lindenmann 1984). They may originate from within the 
body (known as “self”) or from the external environment (known as “foreign”). In healthy individuals 
the immune system is under homeostatic conditions non-reactive against self-antigens due to several 
mechanisms, such as the elimination of self-reactive lymphocytes during their development (Reviewed 
by (Starr, Jameson et al. 2003)) or the inactivation or the suppression of these cells by regulatory T-cells 
(Tregs) (Reviewed by (Sakaguchi 2004)).  Adaptive immune responses can be subdivided into the 
humoral immunity and cell-mediated immunity. The humoral immunity is mediated by antibodies 
(Abs) secreted by B-lymphocytes (also called B-cells) and their fully differentiated progeny, the plasma 
cells. Abs recognize foreign antigens, such as antigens from microbes, then neutralize the infectivity of 
these microbes and lastly target these microbes for elimination through various effector mechanisms.  
1.1.2 Cellular interactions between T-cells and antigen presenting cells 
Cell-mediated immunity is mediated by T-lymphocytes, which either activate phagocytic macrophages 
to kill microbes or transformed body cells (known as helper T-cells) or destroy infected or transformed 
cells through their cytotoxic granules, which contain  perforin and granzymes (known as cytotoxic T-
lymphocytes (CTL)) and ligation of the death receptor cluster of differentiation (CD) 95 (Reviewed by 
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(McNeela and Mills 2001)). Whereas helper T-cells express the co-receptor CD4, CTL express the co-
receptor CD8 and are of major interest in this thesis. T-cells respond to antigens processed and 
presented by professional antigen presenting cells (APCs) such as B-cells, macrophages and dendritic 
cells (DCs) through distinct mechanisms (Reviewed by (Neefjes, Jongsma et al. 2011)). Human CD4 T-
cells recognize exogenous antigens which are captured and processed by APCs to peptides of 12-15 
residues or more and are finally bound to the peptide-binding cleft of major histocompatibility 
complex (MHC) class II molecules. MHC class II molecules consist of an α and β polypeptide chain. 
CD8 T-cells recognize endogenous antigens, e.g. from viral infection, that are processed to peptides of 
only 8-11 residues in association with MHC class I molecules (Wang and Reinherz 2002). MHC class I 
molecules are composed of a polymorphic α chain that is non-covalently attached to the non-
polymorphic β2-microglobulin. In humans, MHC is also referred to as human leukocyte antigens 
(HLA). Whereas MHC class I corresponds to HLA-ABC, MHC class II corresponds to HLA-DR, DP, 
DQ (Bodmer, Marsh et al. 1994).  
1.1.3 T-cells in blood and tissues 
Upon maturation, T-cells leave the thymus via the blood stream to populate the secondary lymphoid 
organs, such as lymph nodes (LNs), tonsils, the spleen or Payer’s patches. In secondary lymphoid 
organs the immune responses are initiated by T-cell-APC interactions and T-cells migrate as activated 
T-cells to multiple tissue sides where they exert immune surveillance by scanning for microbial 
infections or transformed cells (Reviewed by (Germain and Stefanova 1999)). Although most activated 
effector T-cells die after a brief life-span, a subset of primed T-cells develops into long-lived memory 
T-cells that persist as heterogeneous populations in the human body and accumulate with age 
(Reviewed by (Farber, Yudanin et al. 2014)). Approximately 1% of the body’s T-cells found in the 
blood stream are in transit while the rest of the T-lymphocytes are searching for antigens in the tissue, 
where the initiation and execution of effector functions occurs (Sathaliyawala, Kubota et al. 2013).  
Human T-cell subsets in blood and tissue can be phenotypically characterized by the 
expression of the common leukocyte antigen CD45 isoforms (CD45RA or CD45R0) and/or the 
homing receptor L-selectin (CD62L) (Tough 2002). Whereas naive T-cells express the isoform 
CD45RA, memory T-cells express the isoform CD45R0. Memory T-cells are further subdivided into 
central memory (CD45R0+CD62L+) and effector memory (CD45R0+CD62L-) T-cells. The expression 
of CD62L allows homing of the T-cells to secondary lymphoid organs via high endothelial venules, 
while the absence of CD62L expression leads to an accumulation of T-cells in peripheral tissue.  
Sathaliyawala et al. performed a multi-dimensional analysis of T-cells throughout the human 
body from 24 different donors aged 15–60 years, revealing distinct compartmentalization of naive, 
effector and memory CD4 and CD8 T-cell subsets intrinsic to the tissue site that is remarkably 
consistent in diverse individuals. Effector memory CD4 T-cells predominate in mucosal tissue and 
accumulate as central memory subsets in lymphoid tissue, whereas CD8 T-cells are maintained as naive 
subsets in lymphoid tissue and effector memory CD8 T-cells in mucosal sites (Sathaliyawala, Kubota et 
al. 2013). Sathaliyawala et al. concluded that tissue-resident T-cells exhibit distinct phenotypic and 
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functional properties and differ from circulating T-cell subsets to a greater or lesser extent, depending 
on the tissue-type (Sathaliyawala, Kubota et al. 2013). Nevertheless, due to the lack of healthy human 
tissue-material, both basic immunological research and immune monitoring of T-cell responses are 
almost exclusively performed on blood-derived T-cells.    
1.2 T-cell receptor (TCR)-mediated activation 
1.2.1 TCR signaling and stimulation via MHC/foreign-antigen 
recognition 
T-cells are characterized by the expression of antigen receptor complexes, also known as T-cell 
receptors (TCRs). TCRs are heterodimers consisting of two covalently linked transmembrane 
polypeptide chains, designated TCR α and β, and a non-covalently associated monomorphic CD3 
signaling component (Wang, Lim et al. 1998). Each chain (α and β) consists of one immunoglobulin 
(Ig)-like N-terminal variable domain for specific recognition of MHC/peptide complexes, one Ig-like 
constant domain, a hydrophobic transmembrane region and a short cytoplasmic region. The CD3 
signaling component consists of a series of dimers, including the heterodimer γε, the heterodimer δε 
and the homodimer ζζ. These TCR-associated dimers are essential for intracellular signal transduction 
through the phosphorylation of their intracellular immunoreceptor-tyrosine-based activation motifs 
(ITAMs) (Cambier 1995).   
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1:  TCR/CD3-mediated proximal signaling. Upon TCR complex engagement a phosphorylation cascade is 
induced (Watanabe 2012). © Journal of Clinical & Cellular Immunology 
T-cells are instructed to initiate their developmental and effector programs through stimulation of their 
TCR complex (signal 1) and co-stimulatory molecules (signal 2), such as CD28, which are presented by 
professional APCs (Reviewed by (Sharpe 2009)). Lack of co-stimulatory molecules combined with 
high-affinity TCR complex engagement leads naive T-cells to an anergic state in which they are 
refractory to activation. If both signals are present, protein clustering on the T-cell and the APC is 
initiated. Active reorganization via cytoskeleton-directed movements give rise to the immunological 
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synapse (Kumari, Curado et al. 2014), which is also referred to as a supra-molecular activation cluster 
(SMAC) (Delon and Germain 2000). The SMAC consist of a central region (cSMAC), which consists 
of TCR-MHC/peptide complexes, the co-receptors CD4 or CD8, co-stimulation receptor complexes 
(e.g. CD28-CD80/-CD86), enzymes and adaptor proteins. The peripheral zone (pSMAC) stabilizes the 
cell interaction by adhesion molecules and integrins e.g. the interaction between leukocyte function-
associated antigen-1 (LFA-1) and intracellular adhesion molecule-1 (ICAM-1). CD45 molecules stay 
outside the pSMAC in an area termed the distal SMAC (dSMAC) (Grakoui, Bromley et al. 1999, Delon 
and Germain 2000). During signal transduction, the co-receptors CD4 or CD8 recruit the Src family 
kinases Fyn and Lck (lymphocyte-specific protein tyrosine kinase) close to the TCR complex. 
Additionally, some ITAMs of the heterodimer δε and the homodimer ζζ are phosphorylated as an 
early, prerequisite step for TCR-directed T-cell activation. Conformational changes of partially 
phosphorylated CD3ε and CD3ζ make ITAMs even more accessible for phosphorylation and are 
required for full T-cell activation. Subsequently, ZAP-70 (ζ-chain associated protein kinase 70 kDa) is 
recruited and binds to the transmembrane adaptor protein LAT (linker for the activation of T-cells) 
and the cytosolic adaptor protein SLP-76 (Src homology 2 domain-containing leukocyte 
phosphoprotein of 76 kDa). A cascade of phosphorylation events is initiated which concludes with the 
activation of the transcription factors NF-κB (nuclear factor κB), NFAT (nuclear factor of activated T-
cells) and AP-1 (activation protein-1), which regulate T-cell gene expression related to cytokine 
production (Cham and Gajewski 2005), clonal expansion, metabolism and/or differentiation into 
effector or memory T-cell subsets (Reviewed by (Fox, Hammerman et al. 2005, Smith-Garvin, 
Koretzky et al. 2009, Wahl, Byersdorfer et al. 2012)).  
1.2.2 Tonic TCR signaling via MHC/self-peptide recognition in tissues 
In order to be able to detect antigens during the priming or the effector phase, T-cells actively search 
for MHC/peptide complexes displayed on the surfaces of other cells, which can either be professional 
APCs, mainly DCs in LNs during the priming phase or almost any other cell type of the body during 
immune surveillance (Garbi, Hammerling et al. 2010, Garbi and Kreutzberg 2012, Sathaliyawala, 
Kubota et al. 2013) . This search for antigens is performed by a highly-dynamic crawling process in 
which T-cells crawl in the tissue context along collagen fibrils with an average speed of 10 µm per 
minute (Wolf, Muller et al. 2003, Skokos, Shakhar et al. 2007). The amoeboid migration of the T-cells is 
interrupted by contact periods lasting between 3 and 5 minutes which allow TCRs to recognize MHC 
molecules on the surface of other cells (Friedl and Weigelin 2008). During this scanning process, most 
of the binding interface of the TCRs involves contact between the complementarity-determining 
regions 1 and 2 (CDR1, 2) and the conserved parts of the MHC helices. Thus, TCRs identify MHC 
molecules independent of class or allele (Wu, Tuot et al. 2002, Garcia, Adams et al. 2009).  During 
crawling, integrin-mediated cell adhesion and cytoskeletal rearrangements are essential processes that 
support the slow-down of T-cell migration and the polarization of T-cells (Revy, Sospedra et al. 2001, 
Randriamampita, Boulla et al. 2003, Fischer, Jacovetty et al. 2007, Friedl and Weigelin 2008, Conche, 
Boulla et al. 2009). Integrin-mediated cell contacts as well as low- or intermediate-affinity contacts 
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between TCRs and MHC molecules that are frequently loaded with self-peptides in the tissue context 
pre-sensitize the signaling machinery of T-cells through their induction of tonic TCR signals. Tonic 
TCR signals, which are also referred to as basal TCR signals (Garbi and Kreutzberg 2012) are low 
phosphorylation levels of proximal TCR signaling molecules presented in Figure 1.1 that increase T-
cell sensitivity towards foreign antigens, meaning that lower amounts of MHC/peptide recognition is 
required to trigger full T-cell activation via the additional interaction of CDR3s and antigenic peptide 
residues (Figure 1.2)  (Stefanova, Dorfman et al. 2002, Randriamampita, Boulla et al. 2003, Garbi, 
Hammerling et al. 2010). When T-cells interrupt their search for antigens in the tissue context to travel 
to a different body site via the circulation, they transiently live as dispersed cells without cellular 
contacts and, consequently, lose their pre-activated status and stop being prepared for immediate 
activation (Stefanova, Dorfman et al. 2002, Garbi, Hammerling et al. 2010, Hochweller, Wabnitz et al. 
2010, Romer, Berr et al. 2011).  
 
 
 
Figure 1.2:  Model: MHC/(self-peptide) recognition enhances sensitivity of T-cells to foreign antigens. In 
secondary lymphoid organs low- or intermediate affinity MHC/(self-peptide) recognition of naive T-cells on steady state 
DCs results in tonic TCR signaling and a pre-activated T-cell status that makes cells sensitive to MHC/foreign-peptide 
recognition on DCs activated by inflammatory stimuli. Modified from (Garbi, Hammerling et al. 2010) 
1.2.3 Enhanced foreign-antigen sensitivity of murine T-cell responses 
through tonic TCR signaling 
Mouse models have demonstrated extensively that tonic TCR signaling maintains the sensitivity of 
murine CD4 T-cells towards subsequent foreign antigens in the tissue environment (Stefanova, 
Dorfman et al. 2002, Hochweller, Wabnitz et al. 2010, Garbi and Kreutzberg 2012). Stefanová et al. 
have shown that post-thymic recognition of self-peptide loaded MHC molecules facilitates the antigen 
reactivity of mature CD4 T-cells (Stefanova, Dorfman et al. 2002). Tonic TCR signaling was measured 
by the phosphorylation level of the ZAP-70 associated TCR ζ chains. Freshly prepared, blood-derived 
TCR transgenic CD4 T-cells had nearly undetectable levels of partially phosphorylated TCR ζ chains 
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and displayed a 10-fold lower sensitivity to their cognate antigen, a 17-mer peptide fragment of pigeon 
cytochrome c (PCC 88-104), compared with LN cells from the same animals. Moreover, interruption 
of tonic TCR signals led to a rapid decline in sensitivity to the tested antigen (Stefanova, Dorfman et al. 
2002). Loss of murine CD4 T-cell responsiveness to PCC 88-104 was observed within 15-30 minutes 
from LN-derived T-cells that had been placed in dispersed cultures. The requirement for basal 
activation of murine T-cells for high responsiveness to foreign antigens was also reported by 
Hochweller and colleagues. By using a diphtheria toxin (DT)-based murine model for DC depletion, it 
was shown that DCs support the responsiveness of TCR transgenic CD4 T-cells to titrated amounts of 
the myelin oligodendrocyte glycoprotein (MOG 33-35) peptide, and the responsiveness of TCR 
transgenic CD8 T-cells to the ovalbumin (OVA) agonist peptide SIINFEKL. The role of TCR 
signaling has been further investigated in regard to the polyclonal reactivity of murine T-cells to a 
bacterial superantigen. A dramatically enhanced proliferation of murine T-cells to titrated amounts of 
staphylococcal enterotoxin A (SEA) was observed when T-cells obtained tonic TCR signals by 
contacting DCs before superantigen stimulation (Hochweller, Wabnitz et al. 2010). DC depletion led to 
a 50 % decline in ZAP-70-associated basal TCR ζ phosphorylation in T-cells compared with T-cells 
from DC-sufficient mice, indicating that MHC-expressing DCs sustain tonic TCR signaling in the 
absence of foreign antigens. This is consistent with the decreased T-cell responsiveness and impaired 
immune synapse formation in the absence of MHC-expressing DCs (Hochweller, Wabnitz et al. 2010). 
Interestingly, hyporesponsive T-cells which lack MHC expressing DCs are able to quickly restore their 
antigen sensitivity if pre-incubated with DCs 30 minutes before stimulation with SEA (Hochweller, 
Wabnitz et al. 2010).   
1.3 Restoring transiently lost TGN1412 reactivity of 
circulating CD4 memory T-cells 
An extreme case illustrating the effect of tonic TCR signaling on subsequent T-cell activation is the 
dramatic difference in the response of tissue-resident versus circulating human T-cells to the CD28 
superagonist TGN1412 (now called TAB08 (Tabares, Berr et al. 2014)). TGN1412 binds bivalently to 
laterally exposed determinants of the co-stimulatory molecule CD28, resulting in CD28 crosslinking 
(Luhder, Huang et al. 2003). While conventional PBMC cultures from circulating cells which lack 
cellular interactions fail to respond to this CD28-specific monoclonal Ab (mAb) in soluble form 
(Figure 1.3, middle) (Duff 2006), its application to healthy volunteers in a phase 1 study in 2006 
resulted in a life-threatening cytokine release syndrome (Figure 1.3, left) (Suntharalingam, Perry et al. 
2006). The molecular basis for this all-or-nothing effect is the dependence of CD28-driven T-cell 
activation on a pre-activated TCR signaling machinery which is amplified by the co-stimulatory signal 
at the level of the SLP76 signalosome (Dennehy, Elias et al. 2007).  
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Figure 1.3:  Soluble TGN1412/TAB08-mediated T-cell responses. (Left) Tonic TCR signals are induced by TCR-
HLA/self-peptide complexes between T-cells and professional APCs, mainly DCs, and are amplified by the co-
stimulatory signal at the level of the SLP76 signalosome in lymphoid tissue. (Middle) This phenomenon does not occur 
in freshly isolated PBMC as cell-cell contacts are missing in the circulation. (Right) T-cells in high-density (HD) 
precultured PBMC receive tonic TCR signals by actively scanning for HLA/self-peptide complexes on monocytes which 
mature during short term culture. Modified from Hünig 2011 
1.3.1 HD preculture of PBMCs allows in-vitro responses of human CD4 
T-cells to soluble TGN1412 
Interestingly, TGN1412 reactivity is lost when entering the blood circulation but can be subsequently 
restored by “parking” PBMC in cultures at a 10-fold higher cell density (107 cells/ml) than is used for 
conventional PBMC assays (106 cells/ml) for 48 hours at 37 °C and 5 % CO2 (Romer, Berr et al. 2011). 
This high-density (HD) preculture step, also known as the RESTORE protocol for RESetting T-cells 
to Original REactivity, allows human T-cells to continuously scan HLA/self-peptide complexes on the 
surface of other blood-derived mononuclear cells in the absence of cognate antigen (Figure 1.3, right) 
(Romer, Berr et al. 2011). In contrast to T-cell crawling in lymphoid organs, where DCs function as 
professional APCs presenting HLA/self-peptide complexes to T-cells (Hochweller, Wabnitz et al. 
2010, Garbi and Kreutzberg 2012), T-cell-monocyte interactions are required for the acquisition of T-
cell function in HD precultures of human PBMCs (Romer, Berr et al. 2011). Rapid functional recovery 
of hyporesponsive murine T-cells in the presence of DCs occurs within only 30 minutes (Hochweller, 
Wabnitz et al. 2010), however, 48 hours are needed for functional maturation of human monocytes. 
Upon HD preculture of PBMCs, the monocytes upregulate HLA class I molecules and the co-
stimulatory molecule CD86 and thereby improve their features as accessory cells (Romer, Berr et al. 
2011). Shorter HD preculture steps of only 24 hours are insufficient to restore TGN1412-reactivity of 
CD4 memory T-cells and longer preculture steps of up to three days do not further improve CD4 
memory T-cell responses to TGN1412 (Romer, Berr et al. 2011).  
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1.3.2 HD preculture of PBMCs induces tonic TCR signaling for 
amplification by TGN1412 
Römer et al. confirmed the hypothesis that blood-derived CD4 T-cells lost their primed status, but that 
this status could be later restored during HD preculture by resuming cellular interactions, which 
provided tonic TCR signals for the amplification by TGN1412 (Romer, Berr et al. 2011). Colocalization 
of the TCR/CD3 with tyrosine-phosphorylated proteins by confocal microscopy was shown in human 
LN sections and HD precultured PBMCs, but not in fresh PBMCs (Romer, Berr et al. 2011). 
Moreover, scanning of HLA/self-peptide complexes by T-cells during HD preculture of PBMCs was 
blocked by the addition of monovalent Fab fragments directed against HLA class I and HLA class II. 
This addition resulted in a dramatic reduction of the cytokine response to TGN1412 by CD4 memory 
T-cells (Romer, Berr et al. 2011). Finally, the importance of cellular interactions leading to the 
acquisition of TGN1412 reactivity was investigated using LN-resident human CD4 memory T-cells 
(Romer, Berr et al. 2011). Whereas a high proliferative capacity in response to CD28 superagonist was 
observed for ex-vivo CD4 memory T-cells which were kept on ice in order to avoid the loss of the pre-
activated T-cell status, interruption of cellular contacts in dispersed LN cultures for only 1 hour at 
body temperature led to a dramatic loss of TGN1412 reactivity (Romer, Berr et al. 2011).  
1.4 The RESTORE protocol – a tool for reliable monitoring of 
T-cell responses directed to viral and tumor antigens? 
1.4.1 Monitoring of human T-cell responses specific for viral and tumor 
antigens 
Monitoring of blood-derived T-cell responses directed to viral or tumor antigens is an essential 
component of immunological research, translational science and even clinical settings. The evaluation 
of vaccine efficiency represents only one of multiple applications (Seder, Darrah et al. 2008). Many 
different assays are available that allow the assessment of the immune system for a variety of 
phenotypes and functions. CD8 T-cells specific for viral or tumor antigens can either be detected 
through HLA/peptide multimer staining, an option only available at considerable cost and requiring 
knowledge of the relevant allelic HLA molecules and antigenic peptides involved, or through the 
detection of functional responses to peptide pools, usually the production of the pro-inflammatory 
cytokine interferon-γ (IFN-γ). Cytokine production of T-cells upon antigen contact can be evaluated 
by Enzyme Linked Immuno Spot (ELISPOT) assays, cytokine secretion assays or intracellular cytokine 
staining. A key element for the functional evaluation of T-cell responses is the integrity of the sample, 
which depends on multiple preparation steps, such as the anti-coagulant (Mallone, Mannering et al. 
2011), the time frame between blood drawn and PBMC isolation (Bull, Lee et al. 2007, Afonso, Scotto 
et al. 2010), the storage temperature of unprocessed blood (Olson, Smolkin et al. 2011), the optimal 
cryopreservation and thawing of PBMCs (Filbert, Attig et al. 2013) and the cultivation of blood-derived 
mononuclear cells. With regards to the latter, overnight resting of suspended PBMCs in a tube stored 
with an open lid in an incubator at 37 °C and 5 % CO2 is a common technique used to improve T-cell 
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performance by removing apoptotic cells generated as a result of freezing/thawing (Kutscher, Dembek 
et al. 2013, Santos, Buying et al. 2014). In contrast to the RESTORE protocol developed by Römer et al. 
(Romer, Berr et al. 2011), overnight resting takes place for only 1 day at an undefined cell density. Even 
if the integrity of the sample is optimal, the loss of a functional signaling platform in blood samples in 
comparison to tissue samples has to be considered for reliable immunomonitoring (Stebbings, Findlay 
et al. 2007). 
1.4.2 Aims of this study 
A tissue-like in-vitro response of CD8 T-cell to viral and tumor-associated antigens would be highly 
desirable for immunomonitoring and could improve the generation of CD8 T-cell lines and clones for 
cellular immunotherapy. Therefore, we posed the question as to whether HD preculture of human 
PBMCs would also allow for more sensitive detection of CD8 T-cell responses to viral and tumor-
derived antigens. In the first part of this study (Chapter 4.1, 4.4), I will show that this is indeed the case 
for a broad range of virus-specific peptides and peptide pools derived from human cytomegalovirus 
(HCMV), Epstein-Barr virus (EBV), Influenza A virus and adenovirus (AdV). The determination of 
the optimal preculture conditions for monitoring of antigenic CD8 T-cell responses (Chapter 4.2) is 
followed by studies on cellular interactions underlying the RESTORE protocol (Chapter 4.3) and a 
comparison of antigen-specific T-cell responses in blood and tissue of the same individual (Chapter 
4.5). The promising results obtained from virus-specific T-cell responses encouraged me to test 
whether HD preculture of PBMCs from leukemia patients that had received an allogeneic 
hematopoietic stem cell transplantation (HSCT) facilities CD8 T-cell responses to the tumor-associated 
antigen Wilms tumor 1 (WT1) and whether the protocol can be applied for chronological monitoring 
of WT1-derected T-cell responses arising after transplantation (Chapter 4.6) as well as for the 
generation of CD8 T-cell lines with an improved representation of clones responding to low antigen 
concentrations (Chapter 4.7). Finally, I investigated whether the dramatic increase in antigen sensitivity 
of “restored” CD8 T-cells compared to freshly isolated CD8 T-cells correlates with “tonic signaling”, 
i.e. enhanced tyrosine phosphorylation of proximal TCR signaling components (Chapter 4.8), and with 
a change in gene expression profile tested by ribonucleic acid (RNA) microarray (Chapter 4.9, 4.10). 
1.5 Introductory statement on contributions and previous 
publication  
This thesis was conducted in the research laboratory of Prof. Dr. Thomas Hünig at the Institute for 
Virology and Immunobiology of the University of Würzburg. Experimental procedures of this PhD 
thesis were performed by myself, with the exception of microarray hybridization (technical assistance 
Margareta Göbel), Western blotting (technical assistance Hemant Kumar Joshi) and flow cytometry 
based isolation of CD8 memory T-cells (technical assistance Christian Linden). Dr. Claus-Jürgen 
Scholz (Group Leader, Core Unit SysMed) analyzed the microarray data. PD Dr. Götz Ulrich Grigoleit 
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(Department of Internal Medicine II, University Hospital of Würzburg) provided blood samples of 
leukemia patients, Priv.-Doz. Dr. Stephan Hackenberg (Department of Oto-Rhino-Laryngology, 
Plastic, Aesthetic and Reconstructive Head and Neck Surgery, University Hospital of Würzburg) 
provided human blood and paired tonsils, and Priv.-Doz. Dr. Christian Jurowich (Department of 
General, Visceral, Vascular and Paediatric Surgery, University Hospital of Würzburg) provided human 
blood and small intestine. Synthetic peptides were a kind gift from Prof. Dr. Stefan Stevanović 
(Interfaculty Institute for Cell Biology, Department of Immunology, University of Tübingen) and the 
antibody TAB08 from TheraMAB LLC. Dr. Paula Römer (former PhD student in the laboratory of 
Prof. Dr. Thomas Hünig) optimized the RESTORE protocol for circulating human CD4 T-cells. The 
major part of this research is published in the Journal of the American Society of Hematology 
(Wegner, Hackenberg et al. 2015), which grants permission to use this published material for my 
doctoral thesis. 
  
Wegner, J., S. Hackenberg, C. J. Scholz, S. Chuvpilo, D. Tyrsin, A. A. Matskevich, G. U. Grigoleit, S. 
Stevanovic and T. Hunig (2015). "High-density preculture of PBMC restores defective sensitivity of 
circulating CD8 T-cells to virus- and tumor-derived antigens." Blood. 
2 Material 
2.1 Equipment and supplies 
Equipment / Supplies  Manufacturer  Specifications    
 
10 μl tips  Roth    
1000 μl blue tips  Roth    
200 μl yellow tips  Roth    
24 well plates  Greiner Bio-One  Flat bottom cell culture    
48 well plates  Greiner Bio-One  Flat bottom cell culture    
96 well plates  Greiner Bio-One  Flat bottom cell culture    
96 well plates  Greiner Bio-One  U bottom suspension culture    
Autoclave Melag 
BioAnalyzer Agilent  
Cell counting chamber Neubauer 
Cell strainer  BD Falcon   70 μm nylon mesh 
Centrifuge  Eppendorf   Eppendorf centrifuge 5804 R    
Centrifuge  Heraus   Heraus Megafuge 1.0R  
Centrifuge tubes  Greiner Bio-One  15, 50 ml polypropylene 
Cryotubes  Nunc   Cryotube Vials 1.8 ml  
Dark Box FUJIFILM Intellight Dark Box 
Dispenser tips  Brand   1.25 ml, 2.5 ml 
ELISPOT plates  Millipore   MultiScreen Filter plates (white)   
ELISPOT reader  CTL  ImmunoSpot S5 Versa Analyzer 
Eppendorf tubes Sarstedt  1.5 ml 
 Greiner  2.0 ml 
FACS tubes  BD Biosciences  REF 352052 
Flow Cytometer  BD Biosciences  FACSCalibur, FACS Aria III 
Flow hood  Heraeus Laminar HBB2448 
Freezer Forma Scientific -80 °C 
Freezing container  Nalgene  “Mr Frosty”, 18 vials 
Harvester  Perkin Elmer LAS GmbH 
Heat block Eppendorf Thermomixer comfort 
Hera Cell  Hera  safe hood 
Humidified incubator  Thermo Scientific  HERA Cell 150 
Ice maker Scotsmann 
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Leucosep tubes  Greiner Bio-One  50 ml 
Liquid scintillation counter  Perkin Elmer LAS GmbH  
pH-meter Hanna Instruments HI 1280 
Refrigerator  Liebherr  4 °C, -20 °C 
Separation columns  Miltenyi Biotec 25 LS and LD 
Water bath Lauda    
Western blot equipment BIO-RAD 
Western blot membrane  Roth   Roti-PVDF membrane  
2.2 Software 
Software  Application  Reference 
Adobe Photoshop CS3 Figure preparation  Adobe 
CELLQuest v3.3  FACS data acquisition on BD Biosciences 
 FACSCalibur flow cytometer 
EndNote X5  Reference management  Thomson Reuters 
FCAP Array software v2.0  CBA results analysis  SoftFlow Inc, 
 www.fcaparray.com 
FlowJo v9.5.2  FACS data analysis  TreeStar, Inc 
Graphpad Prism v5  Graphs and  www.graphpad.com  
 Statistical analysis 
Image Reader LAS-3000 v2.0  Dark Box image acquisition  Fujifilm 
ImmunoSpot reader systems  Read ELISPOT plates  CTL 
ImmunoSpot software v4.0  Analyze ELISPOT images  CTL 
Microsoft Office 2011 for MAC  Data management and Microsoft 
 Manuscript preparation 
2.3 Chemicals and reagents 
 
Name  Manufacturer 
7-AAD BD Biosciences 
10X Permeabilization Buffer  eBioscience 
Acrylamid 4K Solution (30 %) AppliChem 
Ammonium persulfate AppliChem 
Annexin V stain ImmunoTools 
Anti-mouse horseradish peroxidase (HRP) BD Biosciences 
Anti-PE Microbeads  Miltenyi Biotec 
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Anti-rabbit HRP BD Biosciences 
Amphotericin B AppliChem 
BD FACSRinse Solution  BD Biosciences 
Bovine Serum Albumin (BSA)  Roth 
Brefeldin A Sigma Aldrich  
Ciprofloxacin AppliChem, Fresenius Kabi 
Chloroform Sigma Aldrich 
Collagenase type IV Sigma Aldrich  
Cotrim-ratiopharm Ampoules SF480 mg/ 5 ml Ratiopharm 
Dimethylsulfoxide (DMSO)  AppliChem 
Dithiothreitol (DTT) AppliChem 
DNase type I Sigma Aldrich 
Ethanol  AppliChem 
Ethylenediaminetetraacetic acid (EDTA) Roth 
Fetal calf serum (FCS) Gibco 
Gentamicin sulfate AppliChem 
Glycerol AppliChem 
HBSS, no Calcium, no Magnesium Gibco 
HEPES  AppliChem 
Human Serum Type AB from Male AB Sigma Aldrich  
Isopropanol  Roth 
Lymphocyte separation medium  PAA, CEDARLANE 
Milk powder Real 
Methanol Sigma Aldrich 
NBT/BCIP Liquid Substrate System  Sigma Aldrich 
Non-essential amino acids  Invitrogen 
NP-40 AppliChem 
Paraformaldehyde  Sigma Aldrich 
Penicillin INFECTOPHARM 
Percoll GE Healthcare Life Sciences 
Phosphatase inhibitor Cocktail 2 Sigma Aldrich 
Pro5® Recombinant HLA-A0201 Pentamer Proimmune 
Pro5® Recombinant PP65_HCMV 495-503 Pentamer Proimmune 
Protease inhibitor Cocktail  Sigma Aldrich 
RNAse Zap Sigma Aldrich 
RPMI Medium 1640  Gibco 
RPMI Medium 1640 - L-Glutamine Gibco 
Sodium acetate (NaOAc) AppliChem 
Sodium azide (NaN3)  Roth 
24 2 Material 
Sodium chloride (NaCl) Sigma Aldrich 
Sodium deoxycholate Roth 
Sodium dodecyl sulfate (SDS)  Roth 
ß-Mercaptoethanol  Invitrogen 
Streptavidin-AP Southern Biotech 
Streptomycin sulfate AppliChem 
TEMED  AppliChem 
Tris AppliChem 
Triton X-100  Roth 
Trypan blue  Sigma Aldrich 
Tween-20 AppliChem 
TRIzol reagent Ambion  
Water, Ampuwa Fresenius Kabi 
Water, RNase-free, DEPC treated    Affymetrix 
WesternBright Chemiluminescent HRP Substrate Biozym Scientific  
2.4 Buffers, media and solutions 
BSS (balanced salt solution) / 0.2 % BSA (bovine serum albumin) (BSS/BSA) 
BSS I  1100 ml 
BSS II   1100 ml 
BSA  20.0 g 
ddH2O ad  10.0 l 
 
BSS I 
Glucose  100 g 
KH2PO4  6.0 g 
Na2HPO42H2O  23.8 g 
Phenol red  1.0 g 
ddH2O ad  10.0 l 
 
BSS II 
CaCl22H2O  18.6 g 
KCl  40.0 g 
NaCl  800 g 
MgCl26H2O  20.0 g 
MgSO47H2O  20.0 g 
ddH2O ad  10.0 l 
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FACS (fluorescence-activated cell sorting) buffer 
BSA  0.1 % 
Sodium azide  0.01 % in PBS 
 
Freezing medium 
Heat-inactivated human AB serum  50 % 
AB medium   40 % 
DMSO  10 % 
 
HBSS (Hank`s balanced salt solution) /PSGABC 
HBSS 500 ml 
Penicillin / Streptomycin  100 IU/ml  
Gentamicin sulfate   50 µg/ml 
Amphotericin B  2.5 µg/ml 
Co-trimoxazol (Bactrim) 96 µg/ml 
Ciprofloxacin 2 µg/ml 
 
Isotonic Percoll 100 % 
Percoll 378 ml 
PBS 10x 42 ml 
 
Laemmli 5x buffer 
1.25M Tris 2.5 ml 
Glycerol 5.0 ml 
SDS 1.0 g 
DTT 0.8 g 
Bromphenol Blue (1 % solution) 1.0 ml 
ddH2O ad  10.0 ml, pH  6.8 
 
RIPA (Radio Immuno Precipitation Assay) buffer  
NaCl  150 mM 
NP-40 1.0 % 
Sodium deoxycholate 0.5 % 
SDS 0.1 % 
Tris 50 mM, in ddH2O, pH 8.0 
 
PBS (Phosphate buffered saline) 
NaCl  80.0 g 
KCl  2.0 g 
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KH2PO4  2.0 g 
Na2HPO4  11.5 g 
ddH2O ad  10.0 l, pH  7.4 
 
Percoll 67 % 
Isotonic Percoll 100 % 378 ml 
RPMI Medium 1640 65 ml 
 
Percoll 30 % 
Isotonic Percoll 100 % 60 ml 
PBS 1x 140 ml 
 
Resolving buffer 
Tris  91.0 g 
ddH2O ad 300 ml, pH 8.8 
ddH2O ad 200 ml 
SDS   2.0 g 
 
RPMI Medium 1640 - L-Glutamine + 10 % AB serum (AB medium)  
RPMI Medium 1640 - L-Glutamine 500 ml 
Penicillin / Streptomycin (100 IU/ml)  1.2 ml 
Non-essential amino acids (100X MEM)  5.0 ml 
Na-Pyruvate (100 mM)  5.0 ml 
-Mercaptoethanol (50 mM)  500 µl 
HEPES (1 M)  5.0 ml 
10 % heat inactivated human AB serum  50 ml 
 
RPMI Medium 1640 - L-Glutamine + 10 % (2 %) FCS 
RPMI Medium 1640 - L-Glutamine 500 ml 
Penicillin / Streptomycin (100 IU/ml)  1.2 ml 
10 % FCS (2 %) 50 ml (10 ml) 
 
RPMI Medium 1640 /PSGABC 
RPMI Medium 1640 500 ml 
Penicillin / Streptomycin  100 IU/ml  
Gentamicin sulfate   50 µg/ml 
Amphotericin B  2.5 µg/ml 
Co-trimoxazol 96 µg/ml 
Ciprofloxacin 2 µg/ml 
2.4 Buffers, media and solutions 27 
 
RPMI Medium 1640 - L-Glutamine + 2 % FCS /PSGABC + Enzymes  
(Digestion of the lamina propria) 
RPMI Medium 1640 - L-Glutamine 500 ml 
2 % FCS 10 ml 
Penicillin / Streptomycin  100 IU/ml  
Gentamicin sulfate   50 µg/ml 
Amphotericin B  2.5 µg/ml 
Co-trimoxazol 96 µg/ml 
Ciprofloxacin 2 µg/ml 
Collagenase type IV 22.5 IU/ml 
DNase type I 13.5 IU/ml 
 
Stacking buffer 
Tris  6.05 g 
ddH2O ad 40 ml, pH 6.8 
ddH2O ad 60 ml 
SDS   0.4 g 
 
TBS 10x buffer 
Tris-HCl 24.23 g 
NaCl 80.06 g 
ddH2O ad 1.0 l, pH 7.4 
 
TBST (TBS-Tween) buffer 
Tween-20 1 ml 
TBS 10x buffer  100 ml 
ddH2O ad 1.0 l 
 
Transfer buffer 
Tris  15.1 g 
Glycine  72 g 
ddH2O ad 4.0 l 
Methanol ad 1.0 l 
 
Versene 
KCl  1.0 g 
KH2PO4  1.0 g 
NaHPO4  2.84 g 
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NaCl  41.0 g 
Versene  1.0 g 
ddH2O ad 5.0 l 
 
2.5 Commercial kits 
Kit  Manufacturer 
 
C&E version ExpressArt TRinucleotide mRNA  AmpTec 
amplification Pico kit 
CD8+ T Cell Isolation Kit, human Miltenyi Biotec 
Human IFN-γ ELISPOT Pair BD Biosciences 
IFN-γ Secretion Assay - Detection Kit (PE) Miltenyi Biotec 
IVT PLUS kit  Affymetrix 
Monocyte Isolation Ki II, human Miltenyi Biotec 
PrimeView™ Human Gene Expression Arrays  Affymetrix 
RNeasy Plus Micro Kit QIAGEN 
2.6 Anti-human antibodies  
 
Antigen  Clone/poly  Conjugation  Isotype  Manufacturer 
CD137 4B4-1 PE  Mouse IgG1, κ Miltenyi Biotec 
CD14 M5E2 PE  Mouse IgG2b, κ BD Biosciences 
CD152 (CTLA-4) L3D10 PE  Mouse IgG1, κ Biolegend 
CD25 M-A251 PE  Mouse IgG1, κ BD Biosciences 
CD279 (PD1) EH12.2H7 PerCP/Cy5.5  Mouse IgG1, κ Biolegend 
CD28 15E8 Purified  Mouse IgG1, κ Miltenyi Biotec 
CD28 CD28.2 PE-CyTM5  Mouse IgG1, κ BD Biosciences 
CD3 BW264/56 Purified  Mouse IgG2a, κ Miltenyi Biotec 
CD3 MEM-57 APC  Mouse IgG2a, κ ImmunoTools 
CD3 UCHT1 Alexa647  Mouse IgG1, κ BD Biosciences 
CD357 (GITR) 621 PE  Mouse IgG1, κ Biolegend 
CD3-ξ 6B10.2  Purified   Mouse IgG2a, κ  Santa Cruz 
CD4 MEM-241 PE  Mouse IgG1, κ ImmunoTools 
CD4 RPA-TA PECy5  Mouse IgG1, κ Biolegend 
CD45R0 UCHL1 FITC  Mouse IgG2a, κ BD Biosciences 
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CD62L LT-TD180 APC  Mouse IgG1, κ ImmunoTools 
CD62L LT-TD180 PE  Mouse IgG1, κ ImmunoTools 
CD8 RPA-T8 APC  Mouse IgG1, κ BD Biosciences 
CD8 RPA-T8 PE  Mouse IgG1, κ BD Biosciences 
CD8 UCHT-4 FITC  Mouse IgG2a, κ ImmunoTools 
CD80 B7-1 FITC  Mouse IgM, κ BD Biosciences 
CD86 2331 (FUN-1) PE-CyTM5  Mouse IgG1, κ BD Biosciences  
ERK1/2 polyclonal Purified Rabbit Life Technologies  
GLUT1 202915 PE Mouse IgG2b, R&D Systems 
HLA-ABC G46-26 PE-CyTM5 Mouse IgG1, κ BD Biosciences 
HLA-DR, DP, DQ Tü39 FITC Mouse IgG2a, κ BD Biosciences 
IFN-γ 4S.B3 PE  Mouse IgG1, κ BD Biosciences 
Lck polyclonal Purified Rabbit Cell Signaling 
pCD3-ξ (Tyr142) K25-407.69 Purified  Mouse IgG2a, κ BD Biosciences 
Phosphotyrosine  4G10  Purified  Mouse IgG2b, κ  Millipore 
pSrc family (Tyr416) polyclonal Purified Rabbit Cell Signaling 
pZAP-70 (Tyr319)/Syk (Tyr352) Purified Rabbit  Cell Signaling 
ZAP-70 polyclonal Purified Rabbit  Cell Signaling 
2.7 Cell stimulation reagents 
 
Name  Manufacturer 
E1A_ADE02 19-27 Kind gift of Prof. Stevanović  
HEX_ADE02 37-45 Kind gift of Prof. Stevanović 
HEX_ADE02 901-910 Kind gift of Prof. Stevanović 
HIV-1 pol 476-484 Kind gift of Prof. Stevanović 
Human IL-15 Pepro Tech 
Human IL-17 Pepro Tech 
Human IL-2 (Proleukine) Chiron 
Muromonab-CD3 (OKT3) Janssen-Cilag 
PepMixTM CEF standard JPT Peptide Technologies 
PepMixTM CEFT standard JPT Peptide Technologies  
PepMixTM Human Actin JPT Peptide Technologies 
PepMixTM Influenza A MP1 (H1N1) JPT Peptide Technologies 
PepMixTM Influenza A NP (H3N2) JPT Peptide Technologies 
PP65_HCMVA 495-503 Kind gift of Prof. Stevanović 
TGN1412/ TAB08 Theramab GmbH 
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WT1_HUMAN 126-134 Kind gift of Prof. Stevanović 
WT1_HUMAN 356-364 Kind gift of Prof. Stevanović 
2.8 Human material 
 
Cell type  Source Location 
 
PBMCs  Venous blood   
 Of healthy individuals Transfusion Medicine and Hemotherapy 
 Of patients with hematological  Department of Internal Medicine II 
 malignant disorders University Hospital Würzburg 
 
LPMCs Mucosa of the small intestine Department of Visceral Surgery  
 Of obese patients undergoing  University Hospital Würzburg 
 gastric bypass operation   
  
TMCs  Uninfected tonsils  Department of Oto-Rhino-Laryngology, 
 Of children undergoing tonsillotomy Plastic, Aesthetic and Reconstructive  
   Head and Neck Surgery  
   University Hospital Würzburg 
 
 
3 Methods 
3.1 Cellular methods 
3.1.1 Isolation of human lymphoid cells from blood and tissue 
3.1.1.1 From blood 
Human PBMCs were either prepared from healthy donors as a byproduct of platelet concentrates 
obtained with leukoreduction system chambers (LRS-C) (Dietz, Bulur et al. 2006) or as heparinized 
venous blood from patients with hematological malignant disorders who had undergone myeloablation 
and allogeneic hematopoietic stem cell transplantation. All patients were in complete hematological 
remission at the time of blood sampling. The average time between stem cell transplantation and 
sampling was 814 days; from 166 to 2372 days. PBMCs were obtained by density gradient 
centrifugation with lymphocyte separation medium. Upon washing with ice-cold BSS/ 0.2 % BSA, 
cells were kept on ice until use within one hour or were cryopreserved until analysis. The term “fresh” 
refers to freshly isolated PBMCs tested either directly or after freezing/thawing, which yielded identical 
results (see Figure 4.14).  
3.1.1.2 From lamina propria of the small intestine 
Lamina propria mononuclear cells (LPMCs) were isolated according to a modified method of Bull and 
Bookman (Bull and Bookman 1977). In brief, the mucosal layer was dissected from the fresh tissue 
and washed extensively in antibiotics supplemented culture medium (RPMI Medium 1640 /PSGABC). 
Mucus as well as part of the epithelial cells were removed by carefully scraping the tissue surface with a 
scalpel. Subsequently, the mucosa was cut into 2-4 mm pieces and incubated in a shaking water bath at 
37 °C with 0.7 mM EDTA in HBSS/PSGABC for 45 minutes to remove epithelial cells. This 
incubation was repeated twice. After extensive washing the tissue was incubated in collagenase type IV 
and DNase type I containing digestion medium in a shaking water bath at 37 °C for totally 10-12 
hours. The resulting cell suspension was separated from undigested tissue by filtration through a 
coarse-meshed sieve and finally through a 70 μm nylon mesh. For further isolation of LPMCs, the cell 
suspension was subjected to Percoll density gradient centrifugation and viable mononuclear cells were 
isolated via density gradient centrifugation using lymphocyte separation medium. Cells were washed 
and resuspended in ice-cold RPMI Medium 1640 supplemented with L-Glutamine and 10 % FCS until 
frozen or used.   
32 3 Methods 
3.1.1.3 From tonsils 
Uninfected fresh tonsils were collected from children undergoing tonsillotomy at the University 
Hospital Würzburg. Single-cell suspensions were prepared by cutting the lymphoid tissue into 2-4 mm 
pieces, digestion with collagenase type IV (0.5 mg/ ml) and DNase type I (0.02 mg/ ml) in a shaking 
water bath at 37 °C for 40 minutes, followed by filtration through a 45 μm nylon mesh. Viable tonsillar 
mononuclear cells (TMCs) were isolated by density gradient centrifugation with lymphocyte separation 
medium and were washed with ice-cold BSS/BSA before cells were frozen or used. The applied 
protocol was first described for the isolation of mononuclear cells from liver graft biopsies (33). 
3.1.1.4 Study approval 
Studies using human material were approved by the University of Würzburg Committee on Human 
Research (study numbers 85/13 and 159/13) and by the institutional review board of the University of 
Würzburg. The informed consent was obtained in accordance with the guidelines of the World 
Medical Association`s Declaration of Helsinki. Written Informed consent was obtained from donors 
prior to inclusion in the study. 
3.1.2 Freezing and thawing of mononuclear cells 
Human PBMCs, LPMCs and TMCs were cryopreserved at a concentration of 5x106 cells per 1 ml of 
freezing media. The cell suspension was transferred into cryotubes, which were immediately placed in a 
pre-cooled (4 °C) “Mr. Frosty” Cryogenic Freezing Container filled with isopropanol, stored at -80 °C 
for 24 hours and were then transferred to a -140 °C freezer.  
Cryopreserved vials were briefly thawed in a 37 °C water bath until there was a pea-sized piece of ice 
remaining. Tubes were disinfected before opening under sterile conditions and 1 ml of pre-warmed 
culture medium was added drop wise. The diluted cell suspension was transferred to a 15 ml Falcon 
tube containing 8 ml of pre-warmed culture medium, incubated for 10 minutes at room temperature 
(RT), centrifuged and washed once with medium, resuspended in media and was then kept on ice until 
used.  
3.1.3 Isolation and depletion of subpopulations 
3.1.3.1 Isolation of CD8 T-cells and monocytes 
Circulating CD8 T-cells and monocytes were isolated to ≥ 95 % purity by using the negative CD8 T-
cell Isolation Kit and the positive Monocyte Isolation Kit II from Miltenyi Biotec. Manufacturer`s 
instructions were followed with the only modification of using BSS/BSA instead of the recommended 
buffer. CD8 T-cells from TMCs were positively isolated by using anti-human CD8-phycoerythrin (PE) 
and anti-PE-Microbeads as attempts to isolate tonsillar CD8 T-cells by using the negative CD8 T-cell 
Isolation Kit for human PBMC failed. LS columns were used for all selections. To confirm isolation 
purity cells were labeled with anti-hCD8-PE or anti-hCD14-PE and analyzed by flow cytometry.  
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Besides magnetic activated cell sorting, flow cytometric cell sorting was used as a further method to 
isolate CD8 memory T-cells from PBMCs or TMCs to ≥ 99 % purity. CD8+CD45R0+ cells were 
enriched via labeling of the cells with the conjugates anti-CD8-APC and anti-CD45R0-fluorescein 
isothiocyanate (FITC).   
3.1.3.2 Depletion of regulatory T-cells 
Human regulatory T-cells that constitutively express CD25 on the cell surface were depleted from 
unstimulated fresh or HD precultured PBMCs by using anti-hCD25-PE and anti-PE-Microbeads. 
Purity was confirmed by staining for Foxp3+CD25+CD4+ cells before and after depletion (≥ 98 % 
purity).    
3.1.4 Cell culture and stimulation assays 
3.1.4.1 Standard PBMC cultures and T-cell stimulation 
Cells were cultured in RPMI Medium 1640 supplemented with 10 % AB serum, L-glutamine, 
penicillin, streptomycin, non-essential amino acids, Na-pyruvate, β-mercaptoethanol and HEPES 
(defined as “AB medium”, concentrations of the supplements are given in chapter 2.4) in a humidified 
incubator at 37 °C with 5 % CO2. The cell density for standard T-cell stimulation assays was 2x105 
cells/ 200 µl in a flat-bottom 96-well culture plate or a MiltiScreen® 96-Well ELISPOT plate.  
Virus-specific recall responses were investigated to titrated PepMixTM CEF standard, containing HLA-
class I restricted T-cell epitopes from human cytomegalovirus (HCMV), Epstein-Barr virus (EBV) and 
Influenza A virus, and to a 1:1 combination of the PepMixTM Influenza A MP1 (H1N1) and the 
PepMixTM Influenza A NP (H3N2). The PepMixTM Human Actin was used a negative control pool. 
Synthetic peptides from human cytomegalovirus (PP65_HCMVA 495-503), human immunodeficiency 
virus (HIV-1 pol 476-484), human adenovirus 2 (HEX_ADE02 901-910, HEX_ADE02 37-45 and 
E1A_ADE02 19-27) and Wilms tumor 1 protein (WT1_HUMAN 126-134, WT1_HUMAN 356-364) 
were synthesized by an automated peptide synthesizer 433A following the Fmoc/tBu strategy. 
Synthesis products were analyzed by HPLC and ESI_TOF mass spectrometry. The minimum purity of 
the peptide pools and synthesized peptides was 90 %. Clinical grade of TAB08 and purified anti-CD3 
(OKT3) was used at 1 µg/ ml, Staphylococcus aureus enterotoxin B (SEB) at 0.25 µg/ ml. 
3.1.4.2 RESTORE protocol for human PBMCs 
For RESetting T-cells to Original REactivity, the RESTORE protocol as described by Römer et al. 
(Romer, Berr et al. 2011) was followed. In brief, PBMCs were precultured in AB medium for 2 days at 
high cell density (HD; 1.5x107 cells/ 1.5 ml in 24-well suspension culture plates) [1.9 cm2] to allow 
tissue-like interactions of the cells. Upon HD preculture of PBMCs, cells were harvested and prepared 
for conventional T-cell stimulation assays. 
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3.1.4.3 In-vitro expansion assay 
For in-vitro expansion of antigen-specific CD8 T-cells from fresh or HD precultured PBMCs, cells 
were stimulated at a cell density of 2x106 cells/ ml with 1 µg/ ml of the peptide WT1_HUMAN 356-
364, 0.1 µg/ ml of the PepMixTM CEF standard or the control pool Human Actin (0.1 µg/ ml). On day 
3 of the culture, recombinant human IL-2 (50 IU/ ml), IL-7 and IL-15 (10 IU/ ml) were added. Half-
media change and supplementation of cytokines were performed every 2-3 days until day 14. 
Restimulation was performed in MiltiScreen® 96-Well ELISPOT plates with titrated amounts of the 
respective stimuli.  
3.2 Immunological methods 
3.2.1 Flow cytometry (phenotyping) 
Phenotypic analysis of T-cells and monocytes from fresh or HD precultured PBMCs was performed 
by using fluorochrome-conjugated antibodies directed to the surface molecules CD3, CD4, CD8, 
CD45R0, CD62L, CD137, CD28, GITR, CTLA-4, CD14, CD80, CD86, HLA-A, -B, -C and HLA-
DR, -DP, -DQ. Cells were washed with FACS buffer, stained with the appropriate antibody conjugates 
for 15 minutes at 4 °C, washed with FACS buffer and were fixed with 2 % paraformaldehyde. If 
surface staining was followed by intracellular staining, cells were incubated with Fix/Perm for 30 
minutes, washed 1x with FACS buffer, 1x with Perm/Wash and incubated with antibody conjugates 
against the transcription factors PD-1 and Foxp3 diluted in Perm/Wash for 30 minutes at 4 °C in the 
dark. Cells were washed and resuspended in FACS buffer for flow cytometry using a FACSCalibur 
flow cytometer. Data were analyzed using FlowJo Version 8.8.7. In combination with intracellular 
IFN-γ secretion (see Chapter 3.2.2.1), CD137 surface expression was used to type activated human 
CD8 T-cells.   
3.2.2 Quantification of IFN-γ releasing cells 
IFN-γ secreting T-cells were quantified by three methods: intracellular IFN-γ staining, IFN-γ Enzyme-
Linked ImmunoSpot (ELISPOT) assay and IFN-γ secretion assay.  
3.2.2.1 Intracellular IFN-γ staining 
To analyze intracellular IFN-γ production upon T-cell activation, cytokine secretion was blocked with 
2 µg/ ml Brefeldin A one hour after stimulation. After incubation for another 15 hours, cells were 
stained for surface markers, washed with FACS buffer, permeabilized with Fix/Perm for 30 minutes, 
washed 1x with FACS buffer, 1x with Perm/Wash and incubated with anti-IFN-γ-PE diluted in 
Perm/Wash for 30 minutes at 4 °C in the dark. Cells were washed and resuspended in FACS buffer 
for flow cytometry.   
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3.2.2.2 IFN-γ ELISPOT assay 
IFN-γ Enzyme-Linked ImmunoSpot (ELISPOT) assays were performed with MiltiScreen® 96-Well 
Plates following the instructions of Merck Millipore. Fresh or HD precultured PBMCs were stimulated 
in the presence or absence of the respective stimuli for 16 hours. Negative and positive controls were 
included in each test. For the assay the plate was coated with 5 µg/ ml purified anti-human IFN-γ 
Capture Antibody. Cytokine secreting cells were detected by adding 2 µg/ ml biotinylated anti-human 
IFN-γ Detection Antibody, 1 µg/ ml AP-Streptavidin Conjugate and ready-to-use NBT/BCIP Liquid 
Substrate System. The number of spot-forming cells per well was determined by an ImmunoSpot® S5 
Versa ELISPOT Analyzer.  
3.2.2.3 IFN-γ secretion assay 
IFN-γ secretion sssays were used to quantify IFN-γ releasing CD4 and CD8 T-cells from lamina 
propria. The assay was performed following the instructions of Miltenyi Biotec. In brief, LPMCs were 
prepared for in-vitro stimulation. Cells were resuspended in AB medium and stimulated with titrated 
TAB08 for 16 hours in a humidified incubator at 37 °C with 5 % CO2. As a negative control LPMCs 
remained unstimulated. As a positive control cells were stimulated with 0.25 µg/ ml SEB. 
Subsequently, an IFN-γ specific Catch Reagent was attached to the cell surface of LPMCs, whereas 
each sample contained 1x106 cells. The cells were then incubated for 45 minutes at 37 °C to allow 
cytokine secretion. The secreted IFN-γ was bound to the IFN-γ Catch Reagent on the positive, 
secreting cells. These cells were subsequently labeled with a second IFN-γ-specific antibody, the IFN-γ 
Detection Antibody conjugated to the fluorochrome PE for sensitive detection by flow cytometry. For 
further phenotypic characterization of IFN-γ secreting cells, LPMCs were also stained for CD4 and 
CD8.   
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3.3.1 Western blotting 
3.3.1.1 Sample preparation  
Isolated CD8 T-cells from fresh or HD precultured PBMCs or TMCs (3x106 each) were washed twice 
with ice-cold PBS and lysed in 100 µl of RIPA buffer supplemented with Protease Inhibitor Cocktail, 
Phosphatase inhibitor Cocktail 2 and 1 mM DTT on a shaker at 4 °C for 10 minutes. The lysate was 
centrifuged at 13.000 rpm at 4 °C for 15 minutes and 80 µl of the supernatant was then mixed with 20 
µl of Laemmli 5x buffer prior to boiling at 95 °C for 8 minutes. Denatured, reduced samples were 
frozen at -20 °C for later use.  
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3.3.1.2 SDS-polyacrylamide gel electrophoresis 
Protein extracts were separated on 15 % SDS polyacrylamide gels under reducing conditions. The 
separating gel mix was prepared, poured into the gel apparatus, and overlaid with water. After the gel 
polymerized, the water was descanted and the stacking gel was poured. 14 µl of protein samples were 
loaded, and ran in 1x SDS PAGE running buffer.  
3.3.1.3 Transfer of proteins and staining 
Separated proteins from the SDS-PAGE gel were blotted to a PVDF membrane at 12 V (140 mA) for 
80 min using a semi-dry transfer system. After the transfer, the membrane was washed with methanol 
for 5 min, and was blocked with 5 % milk powder in TBST buffer for 1 hour at RT on a rocker 
platform. The PVDF membrane was then incubated with the primary Ab diluted in TBST buffer plus 
5 % milk powder overnight at 4 °C. The membrane was washed 3x with TBST buffer for 10 minutes 
each time, on the rocker platform at RT, then incubated with a horseradish-peroxidase (HRP) 
secondary Ab for 2 hours, and washed 3x with TBST buffer for 10 minutes each time. The membrane 
was treated with the WesternBright chemiluminescent HRP substrate and developed in the dark box. 
3.3.2 Microarray analysis 
3.3.2.1 Total RNA isolation and ethanol precipitation of nucleic acids 
Total RNA was extracted from isolated CD8+CD45R0+ cells from either fresh or HD precultured 
PBMCs (donor 1-3) or from fresh PBMCs or TMCs (donor 4-6) by the TRIzol method according to 
the instructions of Ambion® Life Technologies. To further purify the isolated nucleic acids, 1/10 
volume of 3M sodium acetate, pH 5.2 and 2-3 volumes of 100 % ethanol were added to each sample, 
mixed and frozen at -80 °C for 20 minutes. Samples were centrifuged at full speed for 30 minutes at 4 
°C. The supernatant was discarded and 200 µl of 70 % ethanol were added. Samples were again spun 
down at full speed for 5 minutes at 4 °C, supernatant was discarded and the pellet was dried with an 
open lid in a heat block set at 55 °C for approximately 5 minutes. The RNA pellet was resuspended in 
10 µl RNase-free water in a heat block for 10 minutes.  High RNA quality was checked using a 
Bioanalyzer 2100 and samples were frozen at -20 °C. 
3.3.2.2 Gene Array 
Expression profiling of RNA from blood and tissue-derived CD8 memory T-cells was performed with 
GeneChip® PrimeView™ Human Gene Expression Arrays. RNA samples were amplified using the 
C&E version ExpressArt TRinucleotide mRNA amplification Pico kit. For the third round of in-vitro 
transcription, we used the IVT PLUS kit for incorporation of biotin-labeled nucleotides. Samples were 
hybridized to GeneChip® PrimeView™ Human Gene Expression Arrays. Data were analyzed using 
the statistical software environment R version 3.1.2 (www.r-project.org) and extensions from the 
Bioconductor project (www.bioconductor.org). Raw signal intensities were normalized by variance 
stabilization (Huber, von Heydebreck et al. 2002). Statistical analysis to select differentially expressed 
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genes was performed using the Linear Models of Microarray Analysis (LIMMA) package (Andersen, 
Svane et al. 2005); we here required a nominal P<.05 and an absolute log fold change of at least 1. 
DAVID was used to search for enriched KEGG pathways (Huang, Sherman et al. 2007). The 
microarray data are available in the Gene Expression Omnibus (GEO) database 
(http://www.ncbi.nlm.nih.gov/geo) under the accession number GSE63430. 
3.4 Statistical analysis 
Data are presented as mean ± SD or median with interquartile range. Statistical significance was 
analyzed by unpaired t test, Wilcoxon matched-paired signed rank test or Mann-Whitney test using 
GraphPad Prism Software. Values of P <.05 were considered to be statistically significant.  
 
 
 
 
 
4 Results 
4.1 HD preculture of PBMCs enhances anti-viral IFN-γ 
responses in human CD8 memory T-cells 
As previously reported, PBMC CD4 T-cells fail to respond to the CD28 superagonist TGN1412 (now 
called TAB08) unless they are first returned to a tissue-like functional status by HD preculture of 
PBMCs for 2 days ((Romer, Berr et al. 2011), Figure 4.1A). It was now asked whether the 
responsiveness of circulating CD8 T-cells to viral antigens is also improved by this preculture 
procedure.  
 
Figure 4.1:  Enhanced anti-viral IFN-γ response in HD precultured human CD8 memory T-cells by HD 
preculture of PBMCs. (A) Representative IFN-γ ELISPOT assay of fresh or HD precultured PBMCs. 
Cytokine release after stimulation with 1μg/ml CD28 superagonist TAB08 (previously: TGN1412) and 0.1 μg/ml 
PepMixTM CEF standard was assessed after 16 hours. Unstimulated fresh and HD precultured PBMCs were used as 
negative controls. (B) Intracellular IFN-γ staining of fresh and HD precultured PBMCs after stimulation with 0.1 
μg/ml PepMixTM CEF standard for 16 hours. Gating was performed on (left) viable lymphocytes and (right) CD8 T-
cells. Experiments were repeated ≥ 3 times.  
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For this purpose, the frequencies of CD8 T-cells responding with IFN-γ release to 0.1 µg/ml of the 
virus-specific PepMixTM CEF standard, containing HLA-class I restricted overlapping 9-mer peptides 
derived from HCMV, EBV and Influenza A proteins, were compared between fresh and HD 
precultured PBMCs by a standard ELISPOT assay in a pilot experiment (Figure 4.1A). Antigen-
independent spot formation was neither observed in fresh nor in precultured PBMCs. Interestingly, 
HD preculture of human PBMCs affected not only CD4 T-cell reactivity to soluble TAB08, but also 
the reactivity of virus-specific CD8 T-cells. Thus, HD precultured PBMCs showed a distinctly higher 
IFN-γ response to the PepMixTM CEF standard relative to fresh PBMCs, indicating that their reactivity 
to viral antigens had increased. Of note, the HD preculture step did not alter the frequency of CD8 T-
cells in the PBMC preparation (Romer, Berr et al. 2011). A further example is given in Table 4.1. 
Whereas 12.0 % CD3+CD8+ T-cells were detected in fresh PBMCs, 11.6 % CD3+CD8+ T-cells were 
detected in HD precultured PBMCs of the same individual.  
The elevated virus-specific IFN-γ response of precultured PBMCs relative to fresh PBMCs was 
confirmed by intracellular cytokine staining, in which CD8 memory cells (CD8+CD45R0+ cells) were 
identified as the main cytokine source (Figure 4.1B).  
4.2 Determination of optimal preculture conditions for 
increasing the sensitivity of CD8 T-cell responses 
As it was important to know whether the preculture conditions established in the original report 
describing the RESTORE protocol for TGN1412-directed CD4 T-cell responses, i.e. 2 days at 1x107 
cells/ ml (Romer, Berr et al. 2011) are also optimal for monitoring of virus-specific blood-derived CD8 
T-cell responses using IFN-γ ELISPOT assays, preculture conditions were varied with regard to time 
(from 1 - 3 days) and cell density (from 1.1 - 30x106 cells/ ml, titration 1:3). High sample integrity was 
the basis for all experiments of this study. As described in chapter 3.1, heparinized venous blood was 
stored at RT, processed within a time frame of eight hours, followed by immediate cryopreservation or 
cell culture. All steps are fixed in a standard operation procedure (SOP) developed in the research 
group of Prof. Dr. Thomas Hünig, Institute for Virology and Immunobiology, University of 
Würzburg.  
The effect of PBMC preculture on virus-directed CD8 T-cell responses turned out to be highly 
dependent on time and density during preculture (Figure 4.2). Unstimulated cells from all preculture 
conditions tested did not release IFN-γ. Preculture at a cell density (≥ 3.3x106 cells/ ml) improved the 
T-cell performance in comparison to fresh PBMCs or PBMCs that were precultured at 1.1x106 cells/ 
ml. However, preculture was not only dependent on the cell density, but also on the time span of 
preculture. Whereas the highest IFN-γ responses were detected in PBMC precultures for 2 days, 
precultures for 1 day or 3 days, respectively at the same cell density were less efficient. Hence, shorter 
preculture steps of only 1 day that would be desirable with regard to time management were less 
effective in comparison to 2 day preculture steps, even if an extremely high cell density (3x107 cells/ 
ml) was chosen. Preculture steps for 3 days at a high cell density (≥ 1x107 cells/ ml) were less efficient 
40 4 Results 
in comparison to 2 day precultures at a similar high cell density. One possible explanation might be a 
lack of nutrients and oxygen, especially during the third day of preculture indicated by a strong pH 
shift of the indicator phenol red to yellow.    
Hence, the preculture conditions established in the RESTORE protocol, i.e. 2 days at 1x107 cells/ ml 
(Romer, Berr et al. 2011) were confirmed as optimal for the detection of antigenic CD8 T-cell 
responses and were used in all further experiments, if not otherwise stated. 
 
Figure 4.2:  Time and density-dependence of the PBMC preculture effect on virus-directed CD8 T-cell                             
responses. CD8 T-cell responses of a healthy donor to 0.1 μg/ml of the PepMixTM CEF standard were obtained by 
IFN-γ ELISPOT assay. PBMC preculture conditions were tested by varying time and cell densities. Unstimulated cells 
from all preculture conditions tested did not release IFN-γ. Data represent mean ± SD for triplicate samples. 
Experiment was repeated ≥ 3 times.  
4.3 Mechanistic studies on restored virus-specific CD8 T-cell 
responses   
4.3.1 Functional maturation of human CD8 T-cells and monocytes 
contribute to the HD preculture effect 
Next, it was tested whether the enhanced IFN-γ response of blood-derived CD8 memory T-cells to 
the PepMixTM CEF standard requires interaction with matured monocytes that develop during the 
preculture step (Romer, Berr et al. 2011). CD8 T-cells and monocytes were purified from fresh or 
precultured PBMCs and were stimulated for 16 hours in ELISPOT plates in the presence or absence 
of CD14+ monocytes isolated from fresh or HD precultured PBMCs of the same individual (Figure 
4.3). In agreement with the results reported above, CD8 T-cells present in unseparated precultured 
PBMCs showed a dramatic increase in the IFN-γ response upon stimulation with 0.1 µg/ml of the 
virus-specific PepMixTM CEF standard as compared to fresh PBMCs. Similarly high responses to the 
PepMixTM CEF standard were observed in 1:1 co-cultures of CD8 T-cells and monocytes if both had 
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been purified from precultured PBMCs, indicating that the maturation of the monocytes during HD 
preculture of PBMCs is required for the strong cytokine response observed after antigen contact. In 
addition, however, HD preculture also pre-sensitizes the CD8 T-cells themselves for the subsequent 
virus-specific response. Thus, purified CD8 T-cells isolated from fresh PBMCs that were co-cultured 
with monocytes prepared from precultured PBMCs showed a response which was as low as that of 
fresh PBMCs. In the absence of monocytes, only CD8 T-cells purified from precultured PBMCs, but 
not from fresh PBMCs showed a small but significant response which is probably due to presentation 
of the virus-derived peptides by the T-cells themselves. Of note, and in agreement with Römer et al. 
(Romer, Berr et al. 2011) the OKT3 response did not discriminate between fresh and HD precultured 
PBMCs. This is explained by the high-affinity interaction of the monoclonal Ab with the TCR complex 
(Adair, Athwal et al. 1994), which obviates the need for priming of the TCR signaling machinery by 
scanning of HLA/self-peptide complexes.  
 
Figure 4.3:  Functional maturation of CD8 T-cells and monocytes contributes to the HD preculture effect. 
CD8 T-cells and monocytes were purified from fresh (F) and precultured (P) PBMCs of the same donor by magnetic 
sorting (MACS) and co-cultured under standard conditions at a 1:1 ratio in the presence of either 0.1 μg/ml 
PepMixTM CEF standard or 1 μg/ml OKT3, and were assessed by IFN-γ ELISPOT 16 hours after stimulation. 
Data represent mean ± SD for triplicate samples for one representative donor out of three.  
As the results presented in Figure 4.3 indicate functional maturation of not only monocytes (Romer, 
Berr et al. 2011), but also CD8 memory cells that additionally contribute to improved virus-specific 
responses, the expression or down regulation of surface molecules and transcription factors allowing 
CD8 T-cells to perform their function was tested by flow cytometry.  Phenotypic analysis of CD8 T-
cells revealed that expression of molecules associated with co-stimulation (CD28) or co-inhibition 
(cytotoxic T-lymphocyte-associated protein 4: CTLA-4), apoptosis (Annexin V binding, 7-AAD 
incorporation) or exhaustion (programmed cell death 1: PD-1) remained unaffected by HD preculture 
of PBMCs, whereas GITR surface expression, a glucocorticoid-induced tumor necrosis factor receptor 
(Ronchetti, Zollo et al. 2004, Ronchetti, Nocentini et al. 2012) increased and CD3 was slightly down 
regulated, possibly as a consequence of MHC scanning (Table 4.1). With regard to CD14+ monocytes, 
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maturation was confirmed by an enhanced expression level (ΔMFI: mean fluorescence intensity) of 
HLA class I (HLA-A, -B, -C) and class II molecules (HLA-DR, -DP, -DQ) and the co-stimulatory 
ligand CD86 upon HD preculture of PBMCs, facilitating cellular interactions between monocytes and 
T-cells. CD80 expression on monocytes of HD precultured PBMCs relative to fresh PBMCs was not 
increased (Table 4.1).  
Table 4.1:  Phenotyping of CD8 T-cells and monocytes from fresh or HD precultured PBMCs. 
Expression of the memory (CD45R0), co-stimulation or co-inhibition (CD28, GITR and CTLA-4), exhaustion (PD-1) or cell 
death (7-AAD, Annexin V) markers on CD8 T-cells as well as the co-stimulation (CD80, CD86) and HLA markers on 
CD14 positive monocytes are given as frequencies (%) and ΔMFI: MFI (specific marker) – MFI (unstained control).  
  % ΔMFI 
within  marker Fresh  Precultured Fresh Precultured 
lymphocytes CD3 CD8 12.0 11.6 117.8 88.8 
CD8 T‐cells CD45R0 38.5 38.0 2.9 4.0 
CD28 74.9 80.5 85.6 91.8 
GITR 56.0 73.4 9.9 17.9 
PD‐1 49.5 48.8 27.0 26.0 
CTLA‐4 * * 4.8 6.7 
7‐AAD 0.8 0.6 2.0 1.8 
Annexin V 0.3 0.7 6.0 6.8 
monocytes CD80 4.3 3.0 5.4 7.4 
CD86 99.1 98.5 261.4 500.2 
HLA‐A,‐B,‐C 99.6 97.9 465.4 1067.4 
HLA‐DR, ‐DP, ‐DQ 99.4 98.5 546.4 926.2 
* no distinct population 
4.3.2 RESTORE effect is not due to a reduction in Treg activity 
To address the mechanistic question whether HD preculture of PBMC induces a gain in reactivity, 
rather than a loss of suppression, e.g. due to an underrepresentation of Treg cells after the preculture 
step, the following experiment was performed. Frequencies of CD25+Foxp3+ cells were compared for 
one representative healthy individual by intracellular staining followed by flow cytometry and turned 
out to be comparable (1.7 % in CD4 T-cells from fresh PBMCs, 1.8 % in CD4 T-cells from 
4.3 Mechanistic studies on restored virus-specific CD8 T-cell responses 43 
precultured PBMCs, Figure 4.4A, left column). Treg cells were depleted from fresh or precultured 
PBMCs by magnetically labeling CD25 positive cells (Figure 4.4A, right column). In agreement with 
the result reported above, HD precultured PBMCs showed a significantly higher reactivity to 0.033-0.3 
µg/ml of the PepMixTM CEF standard as compared to fresh PBMCs (IFN-γ ELISPOT assay, Figure 
4.4B). The reactivity of fresh PBMCs was unchanged if Treg cells were removed prior to the assay and 
it was equally high between CD25 depleted and non-depleted precultured PBMCs. Hence, the 
increased response of HD precultured PBMCs is due to a gain in virus-specific T-cell reactivity rather 
than a reduction in Treg-mediated suppression.  
 
Figure 4.4:  RESTORE effect is not due to a reduction in Treg activity. (A, Left) Similar frequencies of regulatory 
T-cells in unstimulated fresh and precultured PBMCs of a representative healthy donor. Intracellular staining and flow 
cytometry of regulatory T-cells; Gating of Foxp3+CD25+ cells was performed on viable CD4 T-cells. (Right) 
Regulatory T-cells were depleted from fresh or precultured PBMCs by magnetically labeling CD25 positive cells. (B) 
Similar increase in virus-specific CD8 T-cell responses upon HD preculture of total and CD25-depleted PBMCs. Cells 
from Panel A were stimulated with titrated PepMixTM CEF standard in IFN-γ ELISPOT assays. Responses of 
fresh/ CD25 depleted fresh PBMCs and precultured/ CD25 depleted precultured PBMCs, respectively were compared 
by an unpaired t test: n.s.; Significantly enhanced IFN-γ secretion of CD8 T-cells upon HD preculture of total or 
CD25 depleted PBMCs relative to fresh or CD25 depleted fresh PBMCs were detected after stimulation with 0.033 
μg/ml (unpaired t test: ** P <.005), 0.1 μg/ml (* P <.05) and 0.3 μg/ml (** P <.005) of the PepMixTM CEF 
standard. Data represent mean ± SD for triplicate samples. Experiment was repeated 3 times.  
4.3.3 HD preculture prepares T-cells to better respond to antigen, but 
does not increase the frequency of antigen-specific cells 
In order to test if the improved T-cell reactivity upon HD preculture of PBMCs results from an 
increase in frequency of detectable antigen specific CD8 T-cells during the preculture step, HLA 
pentamer staining was performed. Unstimulated fresh, high density (HD: 1x107/ml) or low density 
(LD: 1x106/ml) precultured PBMCs of one representative HLA-A0201 positive healthy donor were 
stained for PP65_HCMV 495-503-specific CD8 T-cells (Figure 4.5). The frequency of CD8 T-cells 
expressing the relevant antigen/MHC specificity remained unchanged independent of the preculture 
step. Pentamer HLA-A0201 was used as a negative control and revealed only a low level of unspecific 
staining.  
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Figure 4.5:  HD preculture prepares T-cells to better respond to antigen, but does not increase the 
frequency of antigen-specific cells. Similar frequencies of PP65_HCMV 495-503-specific T-cells were 
detected in unstimulated Fresh, HD and LD precultured PBMCs by flow cytometry upon pentamer staining. An 
HLA-A0201-restricted pentamer was used as a negative control. Gating was performed on viable CD8 T-cells. 
Experiment was repeated with 2 HLA-A0201 positive healthy donors.  
Taken together, mechanistic studies on “restored” CD8 T-cells have shown that both, monocytes and 
T-cells gain in reactivity upon HD preculture of PBMCs (Figure 4.3, Table 4.1), whereas restored T-
cell performance was independent of Treg-mediated suppression (Figure 4.4) und changes in antigen-
specific CD8 T-cell frequency (Figure 4.5).  
4.4 HD preculture of PBMCs boosts antigen sensitivity of 
virus-specific CD8 T-cells 
The effect of PBMC preculture at HD on the sensitivity of the CD8 T-cell response was then 
quantified by titrating PepMixTM Influenza A (Figure 4.6A) and PP65_HCMV 495-503 (Figure 4.6B). 
IFN-γ responses were tested with freshly prepared PBMCs of healthy individuals, and again after 2 
days of HD preculture. PBMCs were isolated from HLA-A0201 CMV-seropositive donors that were 
used for stimulation with the peptide PP65_HCMV 495-503. Application of the RESTORE protocol 
strongly increased the responsiveness of CD8 T-cells to titrated amounts of the influenza and HCMV 
derived peptides relative to fresh PBMCs as presented for one representative donor in Figure 4.6A and 
B. The displacement of the titration curves of precultured as compared to fresh PBMCs indicates a 5-
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10 fold gain in sensitivity to matrix and nucleocapsid peptides of the Influenza A virus compared to 
fresh PBMCs (Figure 4.6A). Similarly high increases in the sensitivity of CD8 T-cells from precultured 
PBMCs were observed upon stimulation with titrated amounts of PP65_HCMV 495-503 (Figure 
4.6B). Here, HD preculture allowed the detection of a CD8 T-cell response to as little as 0.001 µg/ml 
of that peptide, whereas fresh cells failed to respond with IFN-γ secretion at that antigen 
concentration. Data compiled from six donors showed a significantly increased IFN-γ recall response 
to the PepMixTM Influenza A when HD precultured PBMCs were compared to fresh PBMCs (Figure 
4.6B). The average fold-increase in the response of CD8 T-cells from precultured relative to fresh 
PBMCs is presented as the median with interquartile range after stimulation with titrated PepMixTM 
Influenza A. Three out of nine tested donors did not show IFN-γ responses to PepMixTM Influenza A, 
neither in fresh nor in HD precultured PBMCs and were not included in the summary Figure 4.6B. 
Unresponsiveness of the three excluded donors can be explained by the assumption that those 
individuals have never been in contact with Influenza A-specific peptides, either by previous virus 
infections nor by vaccination prior to this in-vitro test. Responses to titrated PP65_HCMV 495-503 of 
five donors were compiled in Figure 4.6D and presented as in Figure 4.6B. Fold-increases could not be 
calculated for the concentrations 0.0001 and 0.001 μg/ml where no response was detectable in fresh 
PBMCs. Average fold-increases in the HCMV-specific CD8 T-cell response from HD precultured 
PBMCs relative to fresh PBMCs were highly significant (P <.005) if cells were stimulated with 0.01-1 
μg/ml of peptide PP65_HCMV 495-503.  
Since adenovirus-specific CD8 memory T-cells are usually rare in peripheral blood, monitoring of 
patients at high risk for infection, e.g. after allogeneic HSCT is difficult without prior in-vitro expansion, 
which, however, exaggerates their in-vivo representation (Geyeregger, Freimuller et al. 2013). It was 
therefore investigated whether HD preculture of PBMCs also enhances the responsiveness of human 
adenovirus-specific CD8 T-cells to more readily detectable levels. Indeed, CD8 T-cells from seven 
tested healthy individuals showed strongly enhanced  IFN-γ responses to the epitopes HEX 901-910 
presented on HLA-A01, E1A 19-45 presented on HLA-A02 or HEX 37-45 presented on HLA-A24 
molecules from the clinically important strain ADE02 (Figure 4.6E, F). 
In order to obtain a larger data set allowing a statistical assessment of the effects of HD preculture on 
the detection of anti-viral responses within a test population, fresh or precultured PBMCs from 22 
healthy individuals were stimulated with titrated amounts of the virus-specific PepMixTM CEF 
standard. An example of these responses is shown in Figure 4.7A, where CD8 T-cells in precultured 
PBMCs stimulated with 0.033 μg/ml of the PepMixTM CEF standard showed an IFN-γ recall response 
comparable to that of CD8 T-cells in fresh PBMCs stimulated with 0.3 μg/ml of the same peptide 
pool, indicating a 10-fold gain in sensitivity through the HD preculture step. To evaluate whether this 
procedure renders CD8 T-cells responsive to self-peptides that they are usually tolerant of, fresh and 
precultured PBMCs of the same individual as in Figure 4.7A were stimulated with titrated amounts of 
the PepMixTM pool Human Actin (Figure 4.7B). 
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Figure 4.6:  Enhanced sensitivity of human CD8 T-cells to defined viral antigens by HD preculture of 
PBMCs. (A) IFN-γ responses of CD8 T-cells from fresh or precultured PBMCs from a representative healthy donor 
were directly compared by ELISPOT assay after stimulation with titrated PepMixTM Influenza A.  Unpaired t test: 
*** P <.0005; **** P <.0001; (B) Compiled data from 6 healthy donors tested as in Figure 2A. Data represent the 
mean fold-increase in IFN-γ responses of CD8 T-cells from precultured PBMCs relative to CD8 T-cells from fresh 
PBMCs after stimulation with the PepMixTM Influenza A. Mann-Whitney test: * P <.05; ** P <.01. Data 
represent median with interquartile range. (C) IFN-γ responses of CD8 T-cells from fresh or precultured PBMCs from 
a CMV-seropositive healthy donor after stimulation with titrated PP65_HCMV 495-503. (D) Compiled data from 
5 donors tested as in Figure 2C. Data presentation as in Figure 2B. Fold increase could not be calculated for the 
concentrations 0.0001 and 0.001 μg/ml where no response was detectable in fresh PBMCs. (E) CD8 T-cell responses 
in fresh and precultured PBMCs to 2 μg/ml of three different adenovirus-derived peptides. (F) Compiled data from 7 
HLA-A01 (HEX_ADE02 901-910), -A02 (E1A_ADE02 19-27) or –A24 (HEX_ADE02 37-45) 
positive healthy individuals. Data presentation as in Figure 2B.  
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Figure 4.7:  Enhanced recall responses of HD precultured CD8 T-cells to virus-derived peptide pools. (A) 
IFN-γ ELISPOT responses of fresh or precultured PBMCs of one representative healthy donor to titrated amounts of 
the HLA-class I restricted PepMixTM CEF standard. (B) Response of the same donor as shown in Figure 3A to 
titrated amounts of the negative control pool PepMixTM Human Actin. Unpaired t test: * P <.05; ** P <.005; *** P 
<.0005. Data represent mean ± SD for triplicate samples. (C, D) Identification of memory CD8 T-cells as source of 
for IFN-γ production by intracellular cytokine staining of fresh and precultured PBMCs of one representative donor that 
is different from Figure 3A, B. Results are shown as percentage of IFN-γ-positive cells among CD8+CD45R0+ cells 
and CD8+CD45R0- cells. (E) Compiled data from 22 healthy donors tested as in Figure 2A and presented as in 
Figure 2B.  
The unresponsiveness of both fresh and precultured PBMCs to even high concentrations of 9-mer 
peptides of the actin protein demonstrates that HD preculture of PBMCs does not create responses to 
tolerated self-antigens. 
Next, intracellular IFN-γ staining was performed to test whether the boost in antigen sensitivity 
observed over the whole titration range is a feature of the CD8 memory compartment (Figure 4.7C, 
D). Indeed, CD8 memory cells (CD8+CD45R0+) were not only identified as the T-cell subset being 
responsible for the enhanced reactivity to 0.1 µg/ml of the PepMixTM CEF standard (Figure 4.1B), but 
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also as being responsible for the increased sensitivity of the response (Figure 4.7C). CD8 naive T-cells 
(CD8+CD45R0-) did not contribute to the enhanced T-cell sensitivity to PepMixTM CEF if PBMC were 
HD precultured prior to the stimulation assay (Figure 4.7D).  
Data were then compiled from 22 individuals and showed an increased IFN-γ recall response to the 
PepMixTM CEF standard when CD8 T-cells received cell-cell contacts during HD preculture of 
PBMCs prior to stimulation with the viral peptide mix (Figure 4.7E). The average fold-increase in the 
response of CD8 T-cells from precultured PBMCs relative to fresh PBMCs is presented as in Figure 
4.6B. The median with interquartile range (IQR) was found highly significant (P <.0001) after 
stimulation with 0.01 μg/ml (2.3, IQR = 3.0) or 0.1 μg/ml (2.1, IQR = 2.5) of the PepMixTM CEF 
standard. While for some responders, little or no increase (but never a decrease) was seen after HD 
preculture, 5/22 individuals revealed 4-fold or higher increments at both peptide concentrations tested. 
As pointed out above, such increases in detectable IFN-γ responses at individual antigen 
concentrations translate into even higher increases in antigen sensitivity, e.g. the HD precultured cells 
shown in Figure 4.7A have an at least 10-fold higher sensitivity than the non-precultured ones as 
evidenced by the requirement for more than 10-fold higher peptide concentrations of the latter to 
reach comparable responses. 
4.5 Comparison of T-cell responses in blood and tissue  
Continuous cellular interactions in murine (Stefanova, Dorfman et al. 2002) and human (Romer, Berr et 
al. 2011) lymphoid tissue are essential for high sensitivity of CD4 T-cells to peptide antigens. In the 
following chapter 4.5, CD4 and CD8 T-cell functionality measured by IFN-γ secretion was compared 
between blood and tissue. Tissue samples were obtained from lamina propria of the small intestine of 
obese patients undergoing gastric bypass operation at the University Hospital Würzburg. Lamina 
propria mononuclear cells (LPMCs) were isolated in parallel to PBMCs of the same individual, 
followed by phenotyping of T-cell subpopulations and ex-vivo stimulation assays.   
4.5.1 Phenotyping of CD4 and CD8 T-cells from LPMCs and HD 
precultured PBMCs 
As already mentioned in the introduction (chapter 1.1.3), T-cell subsets exhibit distinct phenotypic 
properties depending on their location in the human body, but stay remarkably constant between 
individuals (Sathaliyawala, Kubota et al. 2013). Unstimulated T-cells from blood and lamina propria 
were now characterized by the expression of the common leukocyte antigen isoform CD45R0 and the 
homing receptor L-selectin (Figure 4.8). Results from HD precultured PBMCs and LPMCs originate 
from the same type 2 diabetes negative obese patient (Figure 4.8, upper and middle line). Of note, 
distribution of cell subsets in the blood is independent of HD preculture ((Romer, Berr et al. 2011) and 
data not shown). Hence, results are shown exclusively for HD precultured PBMCs, but not for fresh 
PBMCs. Gating was performed on viable mononuclear cells (MCs, Figure 4.8, left column), CD4 T-
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cells (Figure 4.8, middle column) and CD8 T-cells (Figure 4.8, right column). In blood and LPMCs, 
CD4 T-cell frequencies were higher compared to those of CD8 T-cells. As expected, unequal 
proportions of CD4 memory T-cells (CD45R0+ cells) were found in blood (39.1 %) and lamina propria 
(94.3 %) (Schroder-Braunstein, Pavlov et al. 2012). In contrast, naive T-cells (CD62L+ cells) were 
almost absent in LPMCs (Figure 4.8, middle line), confirming that memory CD4+ T cells represent the 
major subset in mucosal tissues (Sathaliyawala, Kubota et al. 2013). 
In contrast to CD4 T-cell subsets, CD8 T-cell subsets are maintained as effector or central memory 
CD8+ T-cells mainly in mucosal sites e.g. lamina propria (99.5 % within CD8 T-cells) (Sathaliyawala, 
Kubota et al. 2013).  
 
Figure 4.8:  Phenotyping of HD precultured PBMCs, LPMCs and TMCs. Unstimulated mononuclear cells (MCs) 
from the blood (PBMCs), lamina propria of the small intestine (LPMCs) or tonsils (TMCs) were stained with the 
given antibodies to determine their frequency of naïve (CD62L+ CD45R0-), effector (CD62L- CD45R0-), central 
memory (CD62L+CD45R0+) and effector memory (CD62L-CD45R0+) CD4 or CD8 T-cells within living MCs. 
Results from HD precultured PBMCs and LPMCs originate from the same representative obese patient without type 2 
diabetes. Results from TMCs are of another representative tonsil and blood donor. Experiment was repeated ≥ 8 
individuals. 
4.5.2 Loss of T-cell sensitivity to TAB08 in dispersed LPMC cultures 
Experiments from Römer et al. have shown that CD4 T-cells from LNs and HD precultures of 
PBMCs respond to TGN1412 (Romer, Berr et al. 2011). I now compared the results of human LN-
derived CD4 T-cells with those of lamina propria-derived CD4 T-cells and additionally tested LPMCs 
for virus-specific T-cell responses.  
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Cytokine release was compared by IFN-γ ELISPOT assay between blood and mucosal cells upon 
stimulation with 1 µg/ml TAB08 or 1 µg/ml OKT3, respectively. Unstimulated MCs derived from 
blood or lamina propria were used as negative controls and revealed no unspecific responses (Figure 
4.9A). As expected, ex-vivo CD4 T-cell responses to the CD28 superagonist TAB08 were detected in 
human lamina propria and in blood-derived T-cells that were first reset to tissue-like conditions by HD 
preculture of PBMCs, but TAB08-reactivity was absent in fresh PBMCs. According to Figure 4.3, T-
cell responses induced by high-affinity OKT3 binding to the TCR complex are independent of HD 
preculture of PBMCs. IFN-γ responses were next compared to titrated TAB08 (dilution 1:10) between 
LPMCs with those of fresh or precultured PBMCs of the same individual presented in Figure 4.9A, 
and correlated to the frequencies of CD4 T-cells in MCs from blood and mucosal tissue as determined 
by flow cytometry (Figure 4.9B). HD preculture of PBMCs dramatically enhanced the reactivity of 
CD4 T-cells to 0.1 or 1 µg/ml TAB08 to a level that was even higher than for lamina propria T-cells.      
 
Figure 4.9:  IFN-γ release in HD precultured PBMCs and LPMCs in response to TAB08. (A) Representative 
IFN-γ ELISPOT assay of fresh or precultured PBMCs as well as LPMCs of one patient with morbid obesity. 
Cytokine release after stimulation with 1 μg/ml TAB08 (previously: TGN1412) or 1 μg/ml OKT3 was assessed 
after 16 hours. Unstimulated MCs were used as negative controls. (B) IFN-γ responses to titrated TAB08 were 
detected by IFN-γ ELISPOT assays, and correlated to the frequencies of CD4 T-cells in MCs from blood or lamina 
propria as determined by flow cytometry. Statistical comparison of CD4 T-cell responses from LPMCs with those of 
fresh or HD precultured PBMCs. Unpaired t test: **** P ≤ 0.0001, *** P ≤ 0.0005, * P ≤ 0.05. Data represent 
mean ± SD for triplicate samples of one representative patient out of five. 
In order to investigate the loss of high functionality through loss of cellular interactions when entering 
the circulation, LPMCs were either kept disperse in suspension (1x106 cells/ ml) for 2 hours at 37 °C 
and 5 % CO2 to simulate tissue exit or were kept on ice (4 °C) for the same time to maintain high T-
cell sensitivity (Figure 4.10). IFN-γ releases were tested by IFN-γ secretion assay for CD4 (Figure 
4.10A) and CD8 (Figure 4.10B) T-cells of the small intestine to titrated TAB08 (titration 1:5) and 0.25 
µg/ml of the bacterial superantigen Staphylococcus aureus enterotoxin B (SEB) that stimulates all T-cells 
expressing TCRs belonging to the Vβ3 family (Niedergang, Hemar et al. 1995). Unstimulated cells were 
used as a negative control. After stimulation for 16 hours, the IFN-γ secretion assay protocol was 
performed as described in chapter 3.2.2.3. In order to determine the phenotype of IFN-γ secreting 
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cells, LPMCs were additionally stained for CD4 and CD8. Indeed, interruption of cellular contacts at 
37 °C resulted in a significant reduction in the frequency of IFN-γ secreting T-cells to both tested 
stimuli. In contrast to results from HD precultured blood cells (Romer, Berr et al. 2011), TAB08-
directed responses were not exclusively observed in CD4 T-cells (Figure 4.10A), but also to a low 
extent in mucosal CD8 T-cells (Figure 4.10B).  
 
Figure 4.10:  Loss of T-cell reactivity to TAB08 and SEB in LD cultures of LPMCs. LPMCs were either kept on 
ice or dispersed in suspension (1x106 cells/ ml) for 2 hours at 37 °C (5 % CO2) to simulate tissue exit. IFN-γ 
responses of T-cells to titrated amounts of TAB08 (previously: TGN1412) and 0.25 μg/ml SEB were analyzed by an 
IFN-γ secretion assay after stimulation for 16 hours. The IFN-γ secretion assay was combined with surface staining for 
(A) CD4 and (B) CD8 T-cells in order to determine the subtype of IFN-γ cells. Unpaired t test: *** P <.0005, ** P 
<.005. Data represent mean ± SD for triplicate samples of one representative patient with morbid obesity out of two. 
The data support once more the concept that tissue-resident CD4 T-cells, particular lamina propria 
cells or LN cells (Romer, Berr et al. 2011) receive tonic T-cell signals that are amplified upon 
stimulation. Importantly, pre-activation was lost by suspension culture at body temperature, namely 
interruption of cellular interactions.  
Unfortunately, no T-cell responses to viral peptides e.g. to the PepMixTM CEF standard or peptide 
pools of the Varicella-Zoster virus (IE-62, -63, JPT Peptide Technologies) could not be detected in ex-
vivo studies using LPMCs. Therefore, I used uninfected human tonsils as a source of virus-specific 
tissue-resident CD8 T-cells. As viruses enter the human body mainly via the respiratory tract, I 
expected a higher frequency of virus-specific T-cells in tonsil pairs (one of the sites of viral clearance) 
compared to the lamina propria of the small intestine.  
4.5.3 Phenotyping of CD4 and CD8 T-cells from TMCs and HD 
precultured PBMCs 
Tonsillar mononuclear cells (TMCs) were isolated from uninfected tonsils of children undergoing 
tonsillotomy at the University Hospital Würzburg. PBMCs of the same individual were isolated in 
parallel to TMCs, followed by phenotyping of T-cell subpopulations. Gating was performed on viable 
TMCs (Figure 4.8, bottom line left), tonsillar CD4 T-cells (Figure 4.8, bottom line middle) and tonsillar 
CD8 T-cells (Figure 4.8, bottom line right). 
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Similar to the situation in blood and LPMCs, CD4 T-cell frequencies in TMCs (11.9 % within viable 
TMCs) were higher compared to CD8 T-cell frequencies (2 % within viable TMCs, Figure 4.8, left 
column). CD4 T-cell subsets in TMCs were phenotypically much more comparable to those of 
PBMCs, relative to those of LPMCs (Figure 4.8, middle column). Beside effector memory CD4 T-cells 
(56.8 %, CD62L-CD45R0+), naive (16.9 %, CD62L+CD45R0-), effector (4 %, CD62L-CD45R0-) and 
central memory CD4 T-cells (22.4 %, CD62L+CD45R0+) were detected.     
In contrast to CD4 T-cell subsets, CD8 T-cell subsets are mainly maintained as naive cells in lymphoid 
compartments e.g. tonsils (63 % within CD8 T-cells) (Sathaliyawala, Kubota et al. 2013). Hence, 
antigen-experienced CD8 memory T-cells (26.5 % within CD8 T-cells) are rare in TMCs. Upon 
phenotyping of T-cell subpopulations in TMCs, ex-vivo stimulation assays were performed.  
4.5.4 Loss of anti-viral CD8 T-cell sensitivity in dispersed TMC cultures  
Initially, virus-specific CD8 memory T-cell responses to titrated PepMixTM CEF standard (titration 
1:10) were compared by IFN-γ ELISPOT assay between TMCs that were kept on ice or in suspension 
at body temperature. Frequencies of CD8 memory T-cells in TMCs were determined by flow 
cytometry. Interruption of cellular contacts at 37 °C for 2 hours resulted in a 5- to 10-fold reduction in 
antigen sensitivity which can be seen by the displacement of the titration curves in Figure 4.11A. Loss 
in cell viability was not observed (data not shown).  
Next, the ex-vivo responsiveness of tonsillar CD8 memory T-cells to PepMixTM CEF standard was 
compared to that of CD8 memory T-cells in fresh and HD precultured PBMCs of the same individual 
(Figure 4.11B). As predicted from their previous cellular interactions in the lymphatic tissue, CD8 
memory T-cells contained a much (about 10-fold) higher frequency of IFN-γ producers in response to 
0.04 or 0.4 µg/ml of the viral peptide mix as compared to fresh PBMCs. While homing of virus-
specific CD8 memory T-cells to this strategically important site may explain part of this huge 
difference, disablement by loss of tissue context during circulation seems to play an important role as 
evidenced by the strong response of HD precultured PBMCs, which did, however, not reach that 
measured for TMCs of the same individual (Figure 4.11B). 
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Figure 4.11: Loss of virus-specific CD8 T-cell reactivity in dispersed TMCs. (A) Tonsillar mononuclear cells 
(TMCs) were prepared from uninfected fresh human tonsils and were either kept on ice or dispersed in suspension 
(1x106 cells/ ml) for 2 hours at 37 °C (5 % CO2) to simulate tissue exit. IFN-γ responses to titrated amounts of the 
HLA-class I restricted PepMixTM CEF standard were analyzed by an IFN-γ ELISPOT assay, and the frequency of 
CD8 memory T-cells in TMC was determined by flow cytometry. Unpaired t test: * P <.05. (B) Virus-specific IFN-γ 
responses to 0.04 or 0.4 μg/ml of the peptide pool were compared between CD8 memory T-cells from TMCs with those 
of fresh and HD precultured PBMCs of the same individual as presented in Figure 4A.  Similar results were obtained 
after repetition of the experiment. 2way ANOVA *** P <.0005. Data represent mean ± SD for triplicate samples.  
Taken together, CD8 T-cell reactivity in blood to viruses is decreased in comparison to tissue resident 
T-cells from tonsils, but high antigen sensitivity of circulating CD8 T-cells was restored upon HD 
preculture of PBMCs allowing cellular interactions that were lost when leaving the tissue context to 
enter the circulation.  
4.6 Facilitation of CD8 T-cell responses to the tumor-
associated antigen WT1 by HD preculture of PBMCs from 
leukemia patients after allogeneic HSCT 
The enhanced sensitivity of CD8 T-cells from HD precultured PBMCs to multiple virus-specific 
antigens, relative to CD8 T-cells from fresh PBMCs (Figure 4.6, Figure 4.7), led to the important 
question whether HD preculture of PBMCs also improves the detection of tumor-directed CD8 T-
cells. An improvement in the detection of tumor-directed CD8 T-cell responses would be highly 
desirable for immunomonitoring of patients with tumors since blood represents the only routinely 
available source of immune cells. For this study, peptide antigens derived from the extensively studied 
human protein Wilms tumor 1 (WT1_HUMAN) were selected. WT1-specific T-cell responses have 
been elicited in normal donors and implicated in the graft versus leukemia (GVL) effect against acute 
lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML) after myeloablation and allogeneic 
HSCT (Oka, Tsuboi et al. 2002, Rezvani, Brenchley et al. 2005, Rezvani, Yong et al. 2007, Tsuboi, Oka 
et al. 2012).  Consistent with published results, it was found that the frequency of IFN-γ secreting T-
cells specific for peptides derived from the tumor-associated antigen WT1_HUMAN was often low as 
compared to high-avidity CD8 T-cell responses to HCMV, EBV or influenza A (Figure 4.6) (Villacres, 
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Lacey et al. 2003, McMahan and Slansky 2007). As shown in Figure 4.12A, B, “restored” T-cells from 
representative HLA-A-0201 positive AML patients displayed dramatically higher IFN-γ recall 
responses to titrated amounts of the peptides WT1_HUMAN 126-134 and 356-364 than T-cells from 
fresh PBMCs (P <.0005).  
 
Figure 4.12:  HD preculture enhances the recall responses of PBMCs to WT1-derived antigens. (A, B) 
IFN-γ T-cell responses from fresh or precultured PBMCs of one representative HLA-A0201 positive HSCT patient 
to titrated amounts of the peptide WT1_HUMAN 126-134 or WT1_HUMAN 356-364, respectively. Unpaired t 
test: *** P <.0005. Data represent mean ± SD for triplicate samples. The experiment presented in Figure 5A was 
repeated for two different patients. (C) Compiled data from Figure 4B from 11 patients. Average time between stem cell 
transplantation and sampling: 814 days; from 166 to 2372 days.  Data are presented as in Figure 2B. (D) Improved 
monitoring of anti-WT1-directed T-cell responses from an HLA-A0201 positive patient 4 months, 1 year and 5 years 
after HSCT upon HD preculture of PBMCs. Unpaired t test: ** P <.005; *** P <.0005; **** P <.0001. Data 
represent mean ± SD for triplicate samples.  
To demonstrate the specificity of the HLA-A0201-restricted WT1 responses, PBMCs of the human 
immunodeficiency virus (HIV)-seronegative patients presented in Figure 4.12A, B were also treated 
with the HLA-A0201-restricted peptide HIV-1 pol 476-484 (Figure 4.13A, B), and showed no 
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response. Nonspecific effects of WT1 peptides were additionally excluded by the unresponsiveness of 
PBMCs from an HLA-A0201 negative healthy donor with WT1_HUMAN 126-134 and 356-364 
(Figure 4.13C).  Restoration of high T-cell functionality was demonstrated by TAB08 responses 
exclusively in HD precultured PBMCs, but not in fresh PBMCs of all tested patients (Figure 4.13A, B) 
and healthy donors (Figure 4.13C).  
 
Figure 4.13:  Specificity controls of the T-cell responses presented in Figure 4.12 (WT1_HUMAN 126-
134/ HLA-A0201, WT1_HUMAN 356-364/ HLA-A0201). (A, B) PBMC of HIV sero-negative 
hematopoietic stem cell transplanted patients that show WT1 dependent IFN-γ releases to WT1_HUMAN 126-134 
(Figure 4.12A) or WT1_HUMAN 356-364 (Figure 4.12B) were also treated in IFN-γ ELISPOT assays with 
titrated amounts of the irrelevant HLA-A0201-restricted peptide HIV-1 pol 476-484. (C) Nonspecific effects of 
WT1 peptide stimulation were excluded by treating PBMCs of an HLA-A0201 negative healthy donor with titrated 
WT1_HUMAN 126-134 or 356-364. No unspecific responses were detected. Unpaired t test: n.s.; The 
RESTORE effect was demonstrated by TAB08 responses, exclusively in HD precultured PBMCs, but not in fresh 
PBMCs of all tested patients (A, B) and healthy donors (C). Data represent mean ± SD for triplicate samples.  
CD8 T-cell responses to titrated WT1_HUMAN 356-364 (titration 1:2) were compiled from 11 HLA-
A0201 positive AML patients. The average time between allogeneic HSCT and blood sampling was 
814 days, varying from 166 to 2372 days (Figure 4.12C). High fold-increases (P <.0005 or P <.0001) in 
tumor-directed CD8 T-cell responses of precultured PBMCs relative to fresh PBMCs were detected 
after stimulation with 2.5 µg/ml (3.6, IQR = 10.0) 5 µg/ml (9.4, IQR = 14.6) or 10 µg/ml (5.9, IQR = 
14.1) of WT1_HUMAN 356-364. These increases were even higher than the gain in T-cell reactivity 
upon stimulation with the viral peptide mix presented in Figure 4.7E and might be explained by the 
low-avidity TCR repertoire recognizing tumor-associated antigens.  
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The usefulness of the RESTORE protocol for monitoring of anti-tumor T-cell responses of AML 
patients who underwent allogeneic HSCT was tested next. WT1_HUMAN 356-364-specific CD8 T-
cell responses in fresh or HD precultured PBMCs of one representative HLA-A0201 positive AML 
patient were chronologically followed upon transplantation (Figure 4.12D). Anti-tumor responses were 
detected already 4 months after allogeneic HSCT only if the RESTORE protocol, but not if the 
conventional T-cell stimulation assay was used. A dramatically increased WT1 reactivity was observed 
in HD precultured PBMCs relative to fresh PBMCs 1 year after transplantation and was still detectable  
5 years after transplantation (Figure 4.12D). 
As monitoring of tumor-directed T-cell responses is often performed with cryopreserved PBMCs 
because of technical reasons, it was important to test whether an additional freeze/thaw step 
influences the restored T-cell functionality. As presented in an IFN-γ ELISPOT assay for one 
representative HLA-A0201 positive AML patient in Figure 4.14, identical results were obtained in 
(non)-cryopreserved cells after stimulation with titrated WT1_HUMAN 356-364 (titration 1:2).  
 
Figure 4.14:  The RESTORE effect is independent of cryopreservation. PBMCs of a representative leukemia 
patient were frozen, thawed and tested with or without the HD preculture step. IFN-γ secretion of cryroconserved and 
non-cryoconserved fresh or HD precultured samples were compared by an unpaired t test: n.s; The RESTORE effect 
was significantly analyzed by 2way ANOVA. Experiment was repeated ≥ 3 times.  
Taken together, the results presented in Figure 4.12 - Figure 4.14 demonstrate that cellular interactions 
induced by HD preculture of PBMCs dramatically enhance CD8 T-cell sensitivity to the low-avidity 
antigens WT1_HUMAN 126-134 and 356-364.  
4.7 HD preculture allows the generation of CD8 T-cell lines 
with an improved representation of clones responding to 
low antigen concentrations 
Repeated antigen stimulation in the presence of growth-promoting cytokines is often used to generate 
T-cell lines and clones for both analytical and therapeutic purposes. The gain in antigen sensitivity 
during the first round of in-vitro stimulation as a result of HD preculture suggested that without this 
step, CD8 T-cells able to respond to low antigen concentrations if appropriately pre-sensitized by cell 
contacts may be lost from the population and hence be under-represented during later rounds of 
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stimulation. Recall responses of fresh or precultured PBMCs to titrated amounts of the peptide 
WT1_HUMAN 356-364 (titration 1:2) were analyzed before and after antigen-specific CD8 T-cell 
expansion in the presence of the cytokines IL-2, -7 and -15 (Figure 4.15A). Whereas circulating 
functional WT1-specific CD8 T-cell responses were absent or barely measurable in fresh PBMCs of a 
representative HLA-A0201 positive AML patient, CD8 T-cell responses from precultured PBMCs of 
the same individual were easily detectable (Figure 4.15A, left). Importantly, the enhancing effect of HD 
preculture before the first round of stimulation with WT1_HUMAN 356-364 was apparent even after 
long-term culture (Figure 4.15A, right). CD8 T-cells from expanded precultured PBMCs displayed a 
much higher sensitivity (up to 10-fold) after restimulation with titrated peptide WT1_HUMAN 356-
364 (titration 1:2) in comparison to CD8 T-cells from fresh PBMCs that were cultured under the same 
conditions. Of note, the increase in the CD8 T-cell response was particularly striking at low antigen 
doses, suggesting that indeed, the HD preculture step had allowed presensitization-dependent clones 
to participate in the antigen-driven expansion protocol. No responses were observed to PepMixTM 
Human Actin, illustrating the maintenance of peptide specificity (Figure 4.15A, right). To rule out the 
possibility that the observed increase in sensitivity is due to differences in absolute cell number or 
frequency to CD8 T-cells in fresh versus precultured PBMCs after 2 weeks of expansion, flow 
cytometry analyses was performed of fresh or precultured PBMC. After 2 weeks of expansion, the 
absolute cell number decreased from 2x106 PBMC to 1.5x106 in peptide/cytokine expanded fresh and 
1.2x106 precultured PBMC, respectively. CD8 T-cells in viable fresh PBMCs (69 %) were similar in 
frequency as CD8 T-cells in viable precultured PBMCs (68 %, data not shown). To confirm the 
enhanced responsiveness of CD8 T-cells from precultured PBMCs after long-term culture, relative to 
expanded CD8 T-cells derived from fresh PBMCs, CD137 expression was used as a second readout 
for CD8 T-cell activation (Figure 4.16). Whereas only 2.0 % of CD8 T-cells from the fresh PBMC-
derived cultures expressed CD137 upon restimulation with 10 μg/ml of the peptide WT1_HUMAN 
356-364, the frequency of CD137 expressing CD8 T-cells from precultured PBMC–derived cultures 
was increased by a factor of four (8.2 %). Unstimulated CD8 T-cells were negative for CD137 
expression. 
An analogous set of experiments was also performed regarding the generation of virus-specific CD8 T-
cell lines. CD8 T-cells from precultured PBMCs specific for multiple virus-specific peptides showed a 
significantly higher IFN-γ recall response to titrated amounts of the PepMixTM CEF standard (titration 
1:5) as compared to CD8 T-cells from fresh PBMCs (Figure 4.15B, left). Even after dramatic 
expansion of virus-specific CD8 T-cells during long-term culture, the enhanced responsiveness of CD8 
T-cells expanded from precultured PBMCs was maintained if cells were restimulated with low 
concentrations of peptides (0.004 to 0.1 μg/ml, Figure 4.15B, middle). Of note, this enhanced 
response of cells expanded from HD precultured PBMCs remained strictly antigen-dependent. 
Moreover, expansion and re-stimulation with peptides derived from human actin yielded only minute 
responses to this self-antigen using both protocols (Figure 4.15B, right). Together the data indicate that 
CD8 T-cells that receive tissue-like interactions during HD preculture of PBMCs gain in sensitivity to 
virus- and tumor-derived antigens. Sensitization-dependent CD8 T-cells from HD precultured PBMCs 
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Figure 4.16:  CD137 expression on CD8 T-cells from fresh or precultured PBMCs after WT1-specific T-
cell expansion. Fresh or precultured PBMCs of the same HLA-A0201-positive AML patient were 
simultaneously stimulated with 1 μg/ml of the peptide WT1_HUMAN 356-364 in a final cell density of 2x106 
cells/ml and were expanded in the presence of IL-2, IL-7 and IL-15 for 2 weeks. After expansion, cells were 
restimulated with 10 μg/ml WT1_HUMAN 356-364 for 16 hours and stained for CD3, CD8 and CD137. 
Gating was performed on viable CD8 T-cells. 
4.8 Phosphorylation of proximal TCR signaling components 
upon HD preculture of PBMCs  
As previously reported, Stefanová et al. have demonstrated that tonic TCR signaling induced by 
frequent MHC-recognition maintains the sensitivity of murine T-cells towards subsequent foreign 
antigens in the tissue environment (Stefanova, Dorfman et al. 2002). In this studies tonic TCR signaling 
was measured by the phosphorylation level of the ZAP-70 associated TCR ζ chains using 
immunoprecipitation (IP) assays. Phosphorylation levels were enhanced in LN-resident TCR 
transgenic CD4 T-cells, relative to freshly prepared, blood-derived cells from the same animal 
(Stefanova, Dorfman et al. 2002). In the present study Western blotting was performed to compare 
tyrosine phosphorylation of proximal components of the TCR signaling machinery presented in Figure 
1.1 between human CD8 T-cells from fresh PBMCs and those that were first “restored” at HD (Figure 
4.17). In a pilot experiment, CD8 T-cell and monocyte co-cultures (1:1) were lysed, proteins were 
separated under reducing conditions using a 15 % polyacrylamide gel and membranes were finally 
probed with the primary antibody 4G10, which recognizes total tyrosine-phosphorylated proteins in 
CD8 T-cells and monocytes (Figure 4.17A). Several phosphorylated proteins were detected with 
stronger tyrosine phosphorylation in HD precultured co-cultures (P) compared to co-cultures of fresh 
CD8 T-cells and monocytes (F). A band that presented stronger tyrosine phosphorylation in 
precultured cells relative to fresh cells presented a molecular weight of around 19 kDa (Figure 4.17A). 
This 19 kDa band was tested for correspondence to the CD3 ζ chains that undergo multistep tyrosine 
phosphorylated upon TCR engagement resulting in a shift in electrophoretic mobility from 16-21 kDa 
(Koyasu, McConkey et al. 1992, van Oers 1999). Indeed, when using CD3 ζ p-142-specific mAb a 
much higher phosphorylation level in HD precultured-derived CD8 T-cells as compared to freshly 
isolated CD8 T-cells was observed, whereas total CD3 ζ levels remained unchanged (Figure 4.17B). As 
it was shown in mice that different types of TCR engagement are translated into defined CD3 ζ 
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phosphorylation patterns that regulate thresholds for T-cell activation (Kersh, Shaw et al. 1998), 
frequent formation of low-avidity TCR/MHC-self-peptide complexes during HD preculture of 
PBMCs might establish lower thresholds for CD8 T-cell activation compared to CD8 T-cells that lose 
cellular interactions by entering the circulation. In addition, Lck p-Y394 which is required for tyrosine 
phosphorylation of the CD3 ζ chains (Molina, Kishihara et al. 1992, Straus and Weiss 1992) was much 
more pronounced in CD8 T-cells from precultured PBMCs as compared to CD8 T-cells from fresh 
PBMCs (Figure 4.17B), whereas total Lck levels remained unchanged. This result correlates with the 
finding that addition of the Lck inhibitor protein phosphatase 1 (PP1) strongly reduces TGN1412-
specific CD4 T-cell reactivity when added during HD preculture or subsequent stimulation culture, 
whereas a brief pulse before harvest of HD precultures was without effect (Romer, Berr et al. 2011). 
A second band that presented strong tyrosine phosphorylation in precultured relative to fresh 
cells presented a molecular weight of around 70 kDa (Figure 4.17A). This 70 kDa band was tested for 
correspondence to ZAP-70 tyrosine kinase activity. Phosphorylation of Tyr319 is known to be 
required for the positive regulation of ZAP-70 function upon TCR triggering (Di Bartolo, Mege et al. 
1999). Total ZAP-70 levels were comparable in HD precultured-derived CD8 T-cells and freshly 
isolated CD8 T-cells (Figure 4.17B). 
 
Figure 4.17:  HD preculture of PBMCs affects TCR signaling of CD8 T-cells. (A) Total tyrosine phosphorylation 
patterns were compared by Western blotting between freshly isolated CD8 T-cells and monocytes (1:1, F) and HD 
precultured co-cultured CD8 T-cells and monocytes (1:1,P) of one representative donor. After cell lysis, proteins were 
separated under reducing conditions using a 15% polyacrylamide gel. Membranes were probed with 4G10 antibody 
(anti-pTyr). (B) Phosphorylation of proximal TCR signaling components was compared between CD8 T-cells from fresh 
and precultured PBMCs. Membranes were probed with antibodies against CD3ζ p-Y142, CD3ζ, Src p-Y394, Lck, 
ZAP-70 p-Y319/ Syk p-Y352 and ZAP-70 as indicated. ERK1/2 served as a loading control. Experiment was 
repeated ≥ 3 times with the exceptions that membranes were probed with antibody against ZAP-70 p-Y319/ Syk p-
Y352 only once.  
Tyrosine phosphorylation of ZAP-70 was not observed using ZAP-70 p-Y319/ Syk p-Y352 antibody 
which detects endogenous ZAP-70 only when phosphorylated at Tyr319 and also cross-reacts with 
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endogenous tyrosine kinase (Syk) when phosphorylated at Tyr352 (Figure 4.17B). To firmly conclude 
that HD preculture does not induce tyrosine phosphorylation of ZAP-70 and that hence, the observed 
band of 70 kDa in Figure 4.17A is of a different origin, further repetitions of the experiment using cells 
from different donors and antibodies other than ZAP-70 p-Y319/ Syk p-Y352 antibody are necessary. 
Taken together, tonic TCR signaling that is shown by enhanced tyrosine phosphorylation of 
the proximal TCR signaling components e.g. CD3 ζ and Lck in human CD8 T-cells from precultured 
PBMCs, but not from fresh PBMCs gives an explanation for improved CD8 T-cell sensitivity to a 
broad range of viral and tumor-associated antigens.  
4.9 Gene expression analysis of CD8 memory T-cells from 
HD precultured PBMCs and tonsils compared to fresh 
PBMCs  
The mechanism of the RESTORE protocol was further studied using Human Gene Expression 
Arrays. Total RNA was prepared from flow cytometry sorted CD8 memory T-cells (CD8+CD45R0+) 
from fresh (F) and HD precultured (P) PBMCs of three healthy adults (donors 1-3) and from CD8 
memory T-cells from fresh PBMCs and TMCs (T) of three children undergoing tonsillectomy (donors 
4-6). The experimental setup contained samples from both adults and children, as only very few 
amounts of blood were received from children undergoing tonsillectomy. The isolation of RNA out of 
CD8 memory T-cells (CD8+CD45R0+) from fresh, HD precultured PBMCs and TMCs of the same 
child failed.  
Global expression profiles were hierarchically clustered according to their similarity and presented in 
the dendrogram in Figure 4.18A. Expression values of differentially expressed genes were then scaled, 
where dark blue corresponds to the lowest expression and dark red to the highest expression level 
(heatmap, Figure 4.18B). Gene expression profiles of CD8 memory T-cells (CD8+CD45R0+) from 
fresh PBMCs were comparable between adults (F1-3) and children (F4-6) with the exception of donor 
5 (F5) (Figure 4.18A, B), indicating that gene expression was independent of age. Expression profiles 
differed clearly between CD8 memory T-cells from HD precultured PBMCs (P1-3) and TMCs (T5-6) 
as CD8 memory T-cells from TMCs (T5-6) were clustered closer to the ones in fresh PBMCs (F2-4, 6) 
relative to the ones in HD precultured PBMCs (P1-3, Figure 4.18B).  
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Figure 4.18:  Gene expression analysis of CD8 memory T-cells from fresh and HD precultured PBMCs 
and tonsils. Total RNA was prepared for microarray analysis out of flow cytometry sorted CD8 memory T-cells 
(CD8+CD45R0+) from fresh (F) and HD precultured (P) PBMCs of three healthy individuals (1-3) and from CD8 
memory T-cells (CD8+CD45R0+) from fresh PBMCs and TMCs (T) of three children undergoing tonsillectomy (4-6). 
(A) Agglomerative hierarchical clustering of global gene expression profiles. The cumulated length of vertical lines 
connecting two samples is indicative for their similarity. (B) Heatmap of differentially expressed genes showing scaled 
expression values, where dark blue corresponds to the lowest expression and dark red to the highest expression level. 
Next, diffenrentially exressed genes were used for enrichment analyses in order to determine pathways 
that could contribute to the enhanced functionality of MHC scanning cells (Figure 4.19). The radar 
plot in Figure 4.19A shows enriched signaling and metabolic pathways that displayed a globally 
significant enrichment (false discovery rate (FDR) <.05) in at least one comparison. For 13 pathways a 
transformed enrichment FDR (-log10 FDR) is shown. A value of 1.3 or greater corresponds to 
significant enrichment. Differentially expressed genes and the direction of changes are not evident 
from  Figure 4.19A. Differentially expressed genes in CD8 memory T-cells (CD8+CD45R0+) from HD 
precultured versus fresh PBMCs (dark grey area) belong to pathways that are associated with 
metabolism (proteasome, glycolysis, glyconeogenesis, fuctose and mannose metabolism, oxidative 
phosphorylation (OXPHOS), citrat cycle, aminoacetyl and tRNA biosynthesis) and with cellular 
interactions and movements (leukocyte transendothelial migration, antigen processing and presentation 
and actin cytoskeleton). Only few pathways (leukocyte transendothelial migration, antigen processing 
and presentation, intestinal immune network for IgA production, ribosome and o-glycan biosynthesis) 
were found if gene expression in CD8 memory T-cells (CD8+CD45R0+) from TMCs was compared to 
that of CD8 memory T-cells from fresh PBMCs (light grey area). Among the differentially expressed 
genes presented in Figure 4.18, only five genes display concordant expression changes between CD8 
memory T-cells from HD precultured PBMCs and from TMCs relative to fresh PBMCs. These are 
presented in a heatmap of scaled expression values (Figure 4.19B). While 6-phophofructo-2-
kinase/fructose-2,6-biphosphatase (PFKFB3, log fold change (log FC): +1.3), an important regulator 
of glycolysis (Maciolek, Pasternak et al. 2014) was upregulated in “restored” and tissue-resident CD8 
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memory T-cells relative to circulating cells, 4 genes were downregulated (Figure 4.19B). The latter are 
SAM domain and HD domain-containing protein 1 (SAMHD1, log FC: -1.7), a human IFN-γ 
inducible protein (Li, Zhang et al. 2000), integrin, alpha M (ITGAM, log FC: -1.3) and integrin, alpha 6 
(ITGA6, log FC: -2.2) both inplicated in various adhesive interactions (Dana, Fathallah et al. 1991, 
Savino and Silva-Barbosa 1996) and vinculin (VCL, log FC: -1.2), a regulator of the cell structure 
(Ziegler, Liddington et al. 2006). Downregulation of vinculin was shown to enhance cell motility that 
might be important for frequent MHC scanning in tonsils and HD precultures (Ziegler, Liddington et 
al. 2006). As only very few genes were similarly expressed in CD8 memory T-cells from HD 
precultured PBMCs and from TMCs relative to fresh PBMCs no general conclusions were drawn.  
 
 
Figure 4.19:  Comparison of the expression profile of CD8 memory T-cells from HD precultured PBMCs 
and TMCs. (A) Radar plot displaying gene set enrichment results from CD8 memory T-cells (CD8+CD45R0+) 
from HD precultured PBMCs versus fresh PBMCs (dark grey area) and those from TMCs versus fresh PBMCs (light 
grey area). Of the 13 functional clusters / pathways shown, each displayed a globally significant (false discovery rate 
[FDR] <.05) enrichment in at least one comparison. Enrichment FDRs were transformed to –log10 (FDR) and 
displayed along the axis for each pathway; FDR <.05 corresponds to –log10 (FDR) >1.3. (B) Heatmap of genes that 
display concordant expression changes between CD8 memory T-cells (CD8+CD45R0+) from HD precultured PBMCs 
and from TMCs relative to fresh PBMCs. 
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When CD8 memory T-cells (CD8+CD45R0+) from HD precultured PBMCs (P1-3) were compared to 
their fresh counterparts (F1-3) whithout samples from patients 4-6, multiple genes associated with 
metabolism were differentially expressed (Figure 4.20A). While genes involved in glycolysis (33 probe 
sets, 12 genes), fructolysis (9 probe sets, 7 genes) and the pentose phophate pathway (6 probe sets, 4 
genes) were strongly  upregulated, expression levels of genes related to other metabolic pathways such 
as oxidative phosphorylation, citrate cycle, aminoacetyl and tRNA biosynthesis, lipolysis and amino 
acid synthesis remained largely unchanged. Interestingly, metabolic enzymes were consistently 
upregulated in order to facilitate the transformation from glycose-6-phosphate to pyruvate (glycolysis) 
that is further transformed to lactate via lactate dehydrogenase A (LDHA, lactic acid fermentation), an 
enzyme which also regenerates oxidized nicotinamide adenine dinucleotide (NAD+) needed for 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Figure 4.20B). The results indicate that CD8 
memory T-cells in HD precultured PBMCs apparently reprogram their metabolism in preparation for 
antigenic stimulation.  
 
Figure 4.20:  HD preculture of PBMCs affects metabolism of CD8 memory T-cells. Differentially expressed 
glycolysis pathway genes from a comparison of CD8 memory T-cells (CD8+CD45R0+) from fresh and HD precultured 
PBMCs are shown (A) in a heatmap of scaled expression values and (B) in a KEGG pathway map with color coded 
log fold changes. (C) Venn Diagram indicating high concordance of changes in glycolysis-related gene expression changes 
between CD8 memory T-cells (CD8+CD45R0+) from fresh PBMCs (presented in 7A and 7B) and pan T-cells from 
LD precultured PBMCs.  
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To exclude the possibility that the enhanced expression of glycolytic genes in CD8 memory T-cells is a 
result of in-vitro culture per se, rather than of the HD preculture conditions which lead to increased 
antigen sensitivity, results presented in Figure 4.20A, B were compared to a previous data set (GEO 
database, GSE51288) in which CD4 and CD8 T-cells were isolated from either high (HD) or low 
density (LD) precultured PBMCs (Figure 4.20C). A large overlap of 11/13 genes associated with the 
“glycolytic pathways” demonstrates that metabolic reprogramming of T-cells is induced specifically by 
cellular interactions provided by HD preculture of PBMCs.  
 
Resting cells metabolize glucose to pyruvate, which enters the mitochondrial citrate cycle and generates 
reducing equivalents for fueling adenosine triphosphate (ATP) production via oxidative 
phosphorylation (OXPHOS). Activated lymphocytes, however, change their metabolism. They engage 
glycolysis where pyruvate is fermented to lactate in the cytoplasm even when sufficient oxygen is 
present to utilize OXPHOS, a process termed originally Warburg effect (Warburg 1956) and later 
aerobic glycolysis (Wang, Marquardt et al. 1976) (Reviewed by (Fox, Hammerman et al. 2005, Lunt and 
Vander Heiden 2011)). Although both processes generate ATP, OXPHOS is more efficient than lactic 
acid fermentation.  As reviewed by Lunt et al., OXPHOS generates 30 ATPs out of one glucose 
molecule, whereas glycolysis followed by lactic acid fermentation generates only two ATP molecules of 
out of one glucose molecule. Hence, activated lymphocytes that increase glycolysis and lactic acid 
fermentation have to take up dramatically higher amounts of glucose compared to resting cells. Those 
high amounts of glucose are imported into the cell mainly via the transmembrane protein glucose 
transporter 1 (GLUT1) that is expressed upon TCR engagement. CD28 co-stimulation has been 
shown to be required for maximal GLUT1 expression (Frauwirth, Riley et al. 2002). GLUT1 surface 
expression, known to be regulated on the translational level (Chakrabarti, Jung et al. 1994, Maciolek, 
Pasternak et al. 2014), was next compared in CD8 memory T-cells between fresh and HD precultured 
PBMCs using flow cytometry. Gating was performed on viable CD8+CD45R0+ cells and expression 
levels of GLUT1 are indicated as Δ MFI  (Figure 4.21). As presented in Figure 4.21A, GLUT1 
expression was significantly increased in CD8 memory T-cells that were first precultured at HD 
compared to freshly isolated CD8 memory T-cells (P <.005). However, in contrast to our expectations, 
strong co-stimulatory signals induced by the CD28 superagonist TAB08 did not further enhance 
GLUT1 expression on HD precultured CD8 memory T-cells. Moreover, already preculture of PBMCs 
at a low cell density (LD) in AB medium significantly increased GLUT1 expression on CD8 memory 
T-cells (one representative healthy donor, Figure 4.21B). Thus, enhanced GLUT1 expression cannot 
be explained by cellular interactions during HD preculture of PBMCs. The observed effect is likely to 
preculture of cells in glucose-rich cell culture media (2 mg/ ml). Replication of the experiments under 
low glucose conditions might be useful to study the effects of HD culture on GLUT1 expression.                                  
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Figure 4.21:  GLUT1 expression in CD8 memory T-cells from fresh and HD precultured PBMCs. 
Unstimulated fresh (F) and HD precultured (P) PBMCs were stained for the glucose transporter 1 (GLUT1). 
Expression values are given as ΔMFI: MFI (GLUT1) – MFI (Isotype control). Gating was performed on viable 
CD8 memory T-cells (CD8+CD45R0+). (A) HD precultured PBMCs were additionally stimulated with 1 µg/ ml 
TAB08. (B) PBMCs were additionally precultured at a low cell density (LD). 
4.10 HD preculture of PBMCs affects integrin expression 
In addition to metabolism-related pathways presented in Figure 4.20A, HD preculture was found to 
affect the expression levels of a number of genes involved in migration (e.g. chemokine receptor 
CXCR4), adhesion (e.g. integrin VLA-4) and cytoskeleton regulation (e.g. paxillin: PXN, vinculin: VCL, 
actin gamma 1: ACTG1). Expression levels of the genes involved in migration, adhesion and cytotoxic 
regulation were lower in HD precultured versus freshly prepared CD8 memory T-cells indicated by the 
blue boxes (Figure 4.22). This counterintuitive observation may reflect the “readiness” of circulating 
CD8 memory T-cells to extravasate.  
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Figure 4.22:  Actin cell adhesion and mobility of CD8 memory T-cells. Color-coded log FC of differentially 
expressed leukocyte transendothelial migration pathway genes from the comparison of CD8 memory T-cells 
(CD8+CD45R0+) from fresh and HD precultured PBMCs are shown in a KEGG pathway map. 
As integrin-induced T-cell adhesion is known to influence T-cell functionality (Friedl and Weigelin 
2008), protein expression levels of the alpha and beta subunits of several integrins such as VLA-4 and 
LFA-1 on leukocytes were also investigated by FACS analysis. Very late antigen 4 (VLA-4) consists of 
the subunits CD49d (integrin alpha 4) and CD29 (integrin beta 1) and binds to vascular cell adhesion 
protein 1 (VCAM-1) or to junctional adhesion molecule B (JAM2) on endothelial cells in order to 
facilitate leukocyte transendothelial migration (see Figure 4.22). Lymphocyte function-associated 
antigen 1 (LFA-1) binds to intercellular adhesion molecule 1 (ICAM-1) on APCs and consists of the 
two subunits CD11a (integrin alpha L) and CD18 (integrin beta 2) (Friedl and Weigelin 2008).  CD11b 
(integrin alpha M) forms heterodimers and is implicated in various cellular interactions.  
Expression levels of the proteins CD11b, CD18, CD49d, CD29 and CD11a were compared between 
CD8 memory T-cells (CD8+CD45R0+) from unstimulated fresh (F) and HD precultured (P) PBMCs 
using flow cytometry and are presented in histograms (Figure 4.23, left) as well as in bar diagrams 
(Figure 4.23, right).  In line with the previously presented RNA microarray data (Figure 4.22), protein 
levels of CD11a, CD11b, CD18 and CD49d were concordantly decreased, whereas CD29 expression 
remained unchanged if cells were first allowed to interact at a HD.  
68 4 Results 
 
Figure 4.23:  Integrin expression of CD8 memory T-cells from fresh and precultured PBMCs. Unstimulated 
fresh (F) and HD precultured (P) PBMCs of one representative healthy donor were surface stained to detect the 
expression of the integrins CD11b, CD18, CD49d, CD29, and CD11a within CD8 memory T-cells 
(CD8+CD45R0+). Isotype stainings (Iso) were used as controls. Mean fluorescence intensities (MFI) are given for each 
staining (left column) and Δ MFI were calculated: MFI (Integrin) – MFI (Isotype); (right column). Staining was 
repeated ≥ 3 times with similar results.  
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5.1 Increased antigen sensitivity of CD8 memory T-cells upon 
HD preculture of PBMCs 
Blood provides the only routinely accessible source of human CD8 T-cells for immunomonitoring and 
the generation of CD8 T-cell lines and clones for cellular immunotherapy. Researchers and physicians 
should, however, be aware of the fact that the large majority of the body’s T-cells reside in tissue, 
especially in bone marrow and lymphatic organs such as thymus, spleen, tonsils, Peyer`s patches in the 
small intestine and LNs, while only 1 % of the cells circulate in the blood stream (Lee, Mandl et al. 
2012, Sathaliyawala, Kubota et al. 2013), and these are transiently less prepared for antigenic stimulation 
(Stefanova, Dorfman et al. 2002). Therefore restoring tissue-like reactivity in blood-derived CD8 T-
cells would be highly desirable. In this study it was tested whether short term in-vitro preculture of 
PBMCs at HD – the RESTORE protocol that was initially described for CD4 T-cell responses to the 
CD28 superagonist TGN1412 (Romer, Berr et al. 2011) – returns circulating virus- and tumor-
associated CD8 T-cells to tissue-like functionality.  
Indeed, a pilot experiment demonstrated that T-cells do not only present an all or nothing effect after 
HD preculture in response to TAB08 (previously called TGN1412) (Romer, Berr et al. 2011), but also 
an increase in responses to MHC class I-presented viral peptides (Figure 4.1A). These first 
observations from IFN-γ ELISPOT assays were confirmed by intracellular cytokine staining, and 
antigen-experienced CD8 memory T-cells (CD8+CD45R0+ cells) were identified as the main source for 
elevated IFN-γ responses in HD precultured compared to fresh PBMCs (Figure 4.1B, Figure 4.7C, D). 
In order to exclude the possibility that the observed effect could be simply secondary to overnight 
resting of human PBMC in an incubator, which has been a standard method for immunological 
functional assays (Kutscher, Dembek et al. 2013, Santos, Buying et al. 2014), preculture conditions were 
varied with regard to time (from 1 – 3 days) and cell density (from 1.1 - 30x106 cells/ ml, Figure 4.2). 
T-cell performance was improved only if cells were allowed to interact at a high cell density (≥ 3.3x106 
cells/ ml). The strongest IFN-γ releases were detected in PBMC precultures for 2 days. Shorter 
preculture steps of only 1 day that are comparable to overnight resting are, of course, desirable in 
regard to time management. Longer preculture steps of up to 3 days were less efficient in comparison 
to precultures for 2 days at a similar high cell density. A lack of nutrients and oxygen, especially during 
the third day of preculture might be an explanation for decreased T-cell performance after 3 days of 
preculture. Hence, the preculture conditions established in the RESTORE protocol, i.e. 2 days at 1x107 
cells/ ml (Romer, Berr et al. 2011) were confirmed to be optimal for the detection of antigenic CD8 T-
cell responses against viruses (Figure 4.2) and tumors (data not shown). As T-cell monitoring is often 
performed on cryopreserved PBMCs, the influence of an additional freeze/thaw step on the restored 
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T-cell functionality was tested and identical results were obtained in (non)-cryopreserved cells after 
WT1-specific stimulation (Figure 4.14). 
IFN-γ ELISPOT assays indicated that the RESTORE protocol prepares T-cells to better respond to a 
broad range of virus-specific (Figure 4.6, Figure 4.7) and tumor-associated antigens (Figure 4.12). 
Upon HD preculture of PBMC, CD8 T-cells gained in antigen sensitivity (Figure 4.6, Figure 4.7, 
Figure 4.12 and Figure 4.15) whereas the frequencies of CD8 T-cells expressing the relevant 
antigen/MHC specificity remained unaffected (Figure 4.5). Moreover, the possibility that the observed 
RESTORE effect is due to a reduction in Treg activity in HD precultured PBMCs relative to fresh 
PBMCs, rather than due to a gain in T-cell sensitivity, was excluded (Figure 4.4B).  
Antigen-independent responses were neither observed in fresh nor in HD precultured PBMC (Figure 
4.1). The increase in the magnitude of CD8 T-cell responses obtained by preculturing PBMC varied 
somewhat between donors and the type of antigen but is overall a robust phenomenon. Thus, 
preculture of PBMC at HD increased the frequency of IFN-γ producing human CD8 T-cells to virus-
specific antigens by 2-fold on average (from 1.2 - 8 fold) if the whole range of antigen doses is 
considered (Figure 4.7E). Remarkably high increases in sensitivity were detected after stimulation with 
titrated amounts of defined virus-derived peptides (Figure 4.6A, C) as well as virus-derived peptide 
pools (Figure 4.7A, C).  
While saturated T-cell responses to multiple virus-specific peptides were already obtained in the 
presence of 0.3 µg/ml of peptide (Figure 4.7A), much higher peptide concentrations of 5-10 µg/ml 
were necessary to trigger saturated T-cell responses to tumor-directed peptides (Figure 4.12A, B). This 
corroborates published results indicating a higher functional avidity of T-cells for APCs displaying 
virus-specific antigens as compared to over-expressed autologous tumor-derived antigens (Villacres, 
Lacey et al. 2003, McMahan and Slansky 2007). In-vitro HD preculture of PBMCs had no influence on 
the sensitivity of T-cells to non-immunogenic self-antigens, as demonstrated by the unresponsiveness 
of fresh and precultured PBMCs to even high concentrations of the PepMixTM Human Actin (Figure 
4.7B, Figure 4.15). The importance of preceding cell-cell interactions for the responsiveness of CD8 T-
cells was unambiguously demonstrated by the high ratio of precultured to fresh PBMC responses 
following stimulation with the HLA-A0201 restricted peptide WT1_HUMAN 356-364 (Figure 4.12C). 
Importantly, the gain in sensitivity by the RESTORE protocol allowed the detection of tumor-directed 
CD8 T-cell responses that were undetectable in PBMC in-vitro tests routinely performed on human 
fresh PBMC (Figure 4.15A, left). High fold-increases in the magnitude of precultured PBMC relative 
to fresh PBMC responses (up to 4-fold) were also observed for T-cells of two HLA-A0201 positive 
patients specific for WT1_HUMAN 126-134 (data not shown). The enhancing effect of preculture of 
PBMC at HD on antigen-specific CD8 T-cell responses to HCMV, EBV, AdV, Influenza A and WT1 
is in accordance with previous investigations of Römer et al.. CD4 T-cell responses to a combined 
tetanus/diphtheria toxoid preparation as well as CD4 and CD8 T-cell responses to SEB (Figure 4.10) 
were greatly enhanced by HD preculture of PBMCs (Romer, Berr et al. 2011). In contrast to all 
antigens tested, the recall responsiveness of CD8 T-cells to an epitope of the tumor-associated protein 
B-cell lymphoma 2 was comparable between fresh and HD precultured PBMC from three HLA-B0702 
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positive AML patients (data published in my Master Thesis). This may be explained by the remarkably 
high anti-BCL2_HUMAN 214-223 CD8 T-cell responses in these patients (Fuji S. 2015), which could 
be secondary to high-affinity recognition by expanded clones which in turn could make them 
independent of cell contact-mediated priming.  
Of note, the enhancing effect of HD preculture on the sensitivity of CD8 T-cells to both 
WT1_HUMAN 356-364  (Figure 4.15A) and viral antigens (Figure 4.15B) was maintained after T-cell 
expansion, resulting in more responsive preparations for experimental or therapeutic purposes 
especially in the low-dose range of antigenic stimulation which may be relevant after transfer in-vivo.  
The enhanced cytokine response of CD8 T-cells expanded from HD precultured PBMC remained 
strictly antigen-dependent and the expansion and re-stimulation with peptides from human actin 
yielded only minute responses to this self-antigen independent of HD preculture prior to long-term 
expansion (Figure 4.15).  
5.2 Enhanced T-cell sensitivity depends on cellular 
interactions  
Continuous cellular interactions provided by the tissue environment or by HD preculture are 
important for the maintenance of full T-cell reactivity (Stefanova, Dorfman et al. 2002, Romer, Berr et 
al. 2011). Preculture at HD resulted in a dramatic increase in CD4 T-cell responsiveness to TAB08, 
approaching the sensitivity observed in lamina propria CD4 T-cells (Figure 4.9). Similar to previous 
experiments performed on human LN-derived CD4 T-cells (Romer, Berr et al. 2011), short-term 
suspension culture of LPMCs at body temperature led to a significant reduction in T-cell 
responsiveness to TAB08 and to the bacterial superantigen SEB (Figure 4.10). The findings on blood 
and tissue-derived CD4 T-cells were extended to anti-viral CD8 memory T-cell responses of the tonsil 
by demonstrating a 5- to 10-fold drop in antigen sensitivity within 2 hours of dispersed culture at body 
temperature (Figure 4.11A). As no information is as yet available regarding how long human T-cells 
remain on average in the circulation before re-entering a tissue, a relatively short time span of 2 hours 
was chosen. Smith and Ford studied lymphocyte recirculation in rats and found that intravenously 
injected cells returned to tissue 4-16 hours after injection (Smith and Ford 1983). Further experiments 
were performed on sheep which, like humans, have large immune systems. The mean lifetime of 
carboxyfluorescein succinimidyl ester (CFSE)-labeled T-cells from 17 animals in blood was calculated 
and ranged between 5.3-20.6 hours, whereas few labeled cells remained remarkably long (>100 hours) 
in blood before trans-endothelial migration to LNs (Thomas, Matejovicova et al. 2012). Hence, 
circulation periods of human T-cells are likely to take even longer than 2 hours on average, resulting in 
a strongly impaired readiness of T-cells to detect antigens. Decreased virus-specific cytokine responses 
were shown in blood-derived CD8 memory T-cells relative to tonsillar cells of the same individual 
(Figure 4.11B). However, the decreased responsiveness of blood-derived CD8 T-cells was partially 
restored upon HD preculture of PBMC allowing cellular interactions (Figure 4.11B). aaaaa 
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5.3 Maturation of monocytes and sub-threshold activation of 
CD8 T-cells contribute to the enhanced T-cell 
functionality 
The importance of returning circulating T-cells to a tissue-like status before testing their antigen-
reactivity cannot be over-estimated. Thus, the functional impairment of CD4 T-cells during their 
sojourn in the blood has been clearly demonstrated in both mice (Stefanova, Dorfman et al. 2002) and 
humans (Romer, Berr et al. 2011), and is associated with a reduction in the phosphorylation and 
polarization of signaling molecules. These phenotypic indicators of the readiness of CD4 T-cells to 
respond to even low numbers of cognate MHC/peptide complexes are restored by an optimized HD 
preculture, which not only enabled vigorous responses to the CD28 superagonist TAB08, but also 
enhanced responses to several tested recall antigens (Romer, Berr et al. 2011). There, the importance of 
cellular contacts involving MHC scanning for this functional maturation was demonstrated by the 
importance of cell density (HD > LD), the inhibitory effects of cell contact prevention by separation 
of low-density from high-density cultured cells by a semipermeable membrane, and the inclusion of 
blocking antibodies to HLA molecules (Romer, Berr et al. 2011). Moreover, colocalization of the 
TCR/CD3 with tyrosine-phosphorylated proteins was shown by confocal microscopy in HD 
precultured PBMCs, but not in fresh PBMCs (Romer, Berr et al. 2011). 
With regard to the mechanisms underlying the increase in sensitivity of “restored” CD8 T-cells, the 
observations made for CD4 T-cells with regard to pre-activation of the TCR signaling machinery were 
extended by demonstrating enhanced tyrosine phosphorylation of Lck and the TCR ζ chains (Figure 
4.17B). The results obtained by Western blotting correlated with the previous finding that addition of 
the Lck inhibitor protein phosphatase 1 (PP1) strongly reduces TGN1412-specific CD4 T-cell 
reactivity when added during HD preculture or subsequent stimulation culture, whereas a brief pulse 
before harvest of HD preculture was without effect (Romer, Berr et al. 2011). Preliminary data 
exhibited enhanced tyrosine phosphorylation of Lck in CD8 T-cells from tonsils and from HD 
precultured PBMCs, but not from fresh PBMC (data not shown), supporting the concept that pre-
activation of T-cells in the tissue-context depends on functional Lck.  
In order to determine pathways that could additionally contribute to the enhanced functionality of HD 
precultured CD8 T-cells, gene expression analysis of CD8 memory T-cells from fresh and HD 
precultured PBMC were performed. Interestingly, multiple genes related to metabolism were 
differentially expressed (Figure 4.19 dark grey area, Figure 4.20). Whereas key enzymes involved in 
glycolysis, fructolysis and the pentose phosphate pathway were upregulated, expression levels related to 
oxidative phosphorylation (OXPHOS) remained largely unchanged (Figure 4.20A). Hence, CD8 
memory T-cells apparently reprogram their metabolism in preparation for antigenic stimulation, similar 
to cancer cells (Warburg 1956), effector T-cells (Gubser, Bantug et al. 2013) and activated macrophages 
(Cheng, Quintin et al. 2014) that exhibit a higher rate of glycolysis even in the presence of oxygen. An 
overview about the metabolic reprogramming of T-cells is given in Figure 5.1 (Chang, Curtis et al. 
2013). Non-proliferating T-cells metabolize glucose to pyruvate, which enters the mitochondrial citrate 
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cycle and generates reducing equivalents for fueling ATP production via OXPHOS. However, 
activated T cells engage glycolysis, where pyruvate is fermented to lactate in the cytoplasm even when 
sufficient oxygen is present to utilize OXPHOS, a process termed the Warburg effect (Warburg 1956) 
or aerobic glycolysis (Wang, Marquardt et al. 1976) (Reviewed by (Fox, Hammerman et al. 2005, Lunt 
and Vander Heiden 2011).  
 
Figure 5.1:  Metabolic reprogramming in T-cells controls T-cell functionality. Resting T-cells metabolize glucose 
to pyruvate, which enters the mitochondrial citrate cycle and generates reducing equivalents for fueling ATP production 
via OXPHOS. Activated T cells engage glycolysis, where pyruvate is fermented to lactate in the cytoplasm even when 
sufficient oxygen is present to utilize OXPHOS (Warburg effect, aerobic glycolysis). Although both processes generate 
ATP, glycolysis is less efficient in producing ATP, indicating that it might provide other advantages such as uptake and 
incorporation of nutrients into the biomass needed for cellular proliferation. Beside T-cell proliferation, aerobic glycolysis 
regulates cytokine production. The key glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) controls 
effector cytokine production on a translational level. (Chang, Curtis et al. 2013) © Cell Press 
Although both processes generate ATP, glycolysis is less efficient, indicating that it might provide 
other advantages during proliferation. It is thought that the metabolism of proliferating cells is adapted 
to facilitate uptake and incorporation of nutrients into the biomass needed to produce a daughter cell; 
i.e., aerobic glycolysis is necessary, both in terms of energy and biosynthesis, for cellular proliferation 
(Vander Heiden, Cantley et al. 2009, Lunt and Vander Heiden 2011). However, cells such as dendritic 
cells exhibit a high rate of glycolysis upon Toll-like receptor-induced activation but do not proliferate 
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(Krawczyk, Holowka et al. 2010). This might be also the case for “restored” CD8 T-cells which do not 
proliferate during HD preculture ((Romer, Berr et al. 2011), Figure 4.1B). This observation suggests 
that aerobic glycolysis may be necessary for pathways other than, or in addition to, those underlying 
proliferation. Recently performed studies by Chang et al. have shown that the key glycolytic enzyme 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is also a positive translational regulator of IFN-
γ production (Chang, Curtis et al. 2013, Gubser, Bantug et al. 2013). GAPDH binds to AU-rich 
elements within the 3` UTR of IFN-γ mRNA and thereby controls effector cytokine production 
(Chang, Curtis et al. 2013).  
Initial observations from gene expression analysis have to be further investigated. Experiments on the 
cellular level might be helpful to test whether the metabolic reprogramming upon HD preculture of 
PBMCs is required for sub-threshold activation of CD8 T-cells. This could be tested by using an 
extracellular Flux Analyzer. The extracellular acidification rate (ECAR), an indicator of aerobic 
glycolysis, and the oxygen consumption rate (OCR), an indicator of OXPHOS can be measured in 
cultures containing CD8 memory T-cells from either fresh or HD precultured PBMCs. Moreover, 
surface expression of the glucose transporter 1 (GLUT1) on CD8 memory T-cells from fresh and HD 
precultured PBMCs (Figure 4.21) could be further tested using cell culture media with glucose 
conditions < 2 mg/ ml.  
In addition to metabolism-related pathways, HD preculture also affected the expression levels of a 
number of genes involved in migration (e.g. chemokine CXCR4), adhesion (e.g. integrin VLA-4) and 
cytoskeleton regulation (e.g. paxillin: PXN, vinculin: VCL, actin gamma 1: ACTG1), where expression 
levels were lower in HD precultured versus freshly prepared CD8 memory T-cells (Figure 4.22). Also 
on the protein level, expression of integrins was decreased (Figure 4.23). Possibly, the higher integrin 
expression in CD8 memory T-cells from fresh relative to HD precultured PBMCs reflects 
“preparedness” of the circulating T-cells for the process of extravasation and migration into tissues. 
Moreover, Friedl et al. described integrin-independent migration of T-cells in three-dimensional multi-
layer structures such as LNs, whereas integrin-mediated attachment of circulating T-cells to two-
dimensional endothelial surfaces is highly dependent on LFA-1/ICAM-1 interactions (Friedl and 
Weigelin 2008). During HD preculture multiple layers of PBMCs can be observed under the 
microscope. Further studies are necessary to test whether T-cells migrate in an integrin-dependent 
manner during the preculture step.  
 
In my study I could show that cellular interactions are important for the functional maturation of both 
interaction partners, CD8 T-cells and monocytes (Figure 4.3). Whereas CD8 T-cells prime their TCR 
signaling machinery by HLA scanning, indicated by a slight downregulation of CD3 molecules (Table 
4.1) and an enhanced tyrosine phosphorylation of proximal TCR signaling components (Figure 4.17B), 
monocytes improve their features as accessory cells by an enhanced expression of HLA molecules and 
the co-stimulatory ligand CD86 (Table 4.1 and (Romer, Berr et al. 2011)). A brief summary of cellular 
maturation events occurring during HD preculture of PBMCs is given in Figure 5.2.  
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Figure 5.2:  Maturation events in blood-derived T-cells and monocytes during HD preculture. During HD 
preculture of PBMCs, monocytes improve their features as accessory cells by an enhanced expression of HLA molecules 
and the co-stimulatory ligand CD86. T-cells frequently interact with matured monocytes by scanning of MHC molecules 
that are loaded with self-peptide. Frequent TCR engagement and co-stimulation (CD28-CD86) results in tonic TCR 
signaling indicated by an enhanced tyrosine phosphorylation of the CD3 ζ chains and Lck. The primed TCR signaling 
machinery of “restored” T-cells in combination with increased glycolysis and lactic acid fermentation (referred to as 
Warburg effect or aerobic glycolysis) which was observed only on the RNA level, but was not on the cellular level until 
now, lowers the threshold for full T-cell activation. 
In contrast to our concept that the enhanced functionality of “restored” T-cells results from tonic TCR 
signaling in responder T-cells, lowering the threshold for full T-cell activation, Hussain et al. report that 
HD preculture induces strong Fc receptor expression on monocytes and that this expression provides 
sufficient interaction with the Fc region of the antibody TGN1412/ TAB08 to induce strong CD4 T-
cell activation. It was concluded that no enhancement of T-cell sensitivity is required, whereas co-
engagement with Fc receptor FcγRIIb is crucial to the agonistic activity of soluble TGN1412. 
(Hussain, Hargreaves et al. 2015). However, in contrast to our study, Hussain and colleagues performed 
the experiments in serum-free media, artificially exposing FcRs to the added stimulatory antibody. 
Moreover, antigen-specific T-cell responses where Fc receptors do not play a role were not tested in 
fresh and HD precultured PBMCs.  
5.4 Few genes displaying concordant expression changes 
between CD8 memory T-cells from tonsils and HD 
precultures of PBMCs 
Contrary to the functionality assays, where “restored” T-cells exhibited a stronger antigen sensitivity 
relative to fresh cells, approaching the sensitivity observed in tissue cells (Figure 4.9, Figure 4.11), gene 
expression analysis revealed that expression profiles differed more between CD8 memory T-cells from 
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tonsillar and HD precultured PBMCs, rather than between CD8 memory T-cells from tonsillar and 
fresh PBMCs (Figure 4.18). Within the differentially expressed genes, only five genes displayed 
concordant expression changes between CD8 memory T-cells from HD precultured PBMCs and from 
TMCs relative to fresh PBMCs (Figure 4.19B). Only one glycolytic enzyme was upregulated in 
“restored” and tissue-resident CD8 memory T-cells relative to circulating cells, and 4 genes related to 
cell adhesion and cell structure were downregulated (Figure 4.19B). It might be interesting to test 
whether knockdown of these 5 genes by small interfering RNAs results in the loss of enhanced T-cell 
functionality in tissue and HD precultures of PBMCs relative to fresh PBMCs.  
It is possible that tonsils, as secondary immunological organs, are not the optimal choice for a 
comparison of gene expression in CD8 memory T-cells derived from either blood or tissue. Even if 
tonsil pairs were removed from children that do not suffer from acute infection at the time of surgical 
removal of the organs, tonsillar T-cells have often previously cleared viral and bacterial infections at 
this strategically important site and were perhaps not in a “resting” state before tonsillotomy. As the 
composition of cell subsets differs depending on the location in the human body, further investigations 
on CD8 memory T-cells from organs different than tonsil might be helpful to detect genes that are 
similarly expressed in tissue and HD precultures of PBMCs.  
5.5 The RESTORE protocol as a promising, cost-effective 
and reliable diagnostic and research tool 
In this thesis it was shown that restoring CD8 T-cell functionality of blood-derived cells by first 
preculturing PBMCs at HD results in a dramatic increase in their responsiveness to various viral and 
tumor-associated antigens, approaching the sensitivity observed in tissue-resident CD8 T-cells. 
Importantly, returning blood-derived T-cells to tissue-like conditions before antigenic stimulation does 
not involve antigen- or cytokine-driven clonal expansion (Figure 4.5), as is used in some protocols to 
reveal otherwise undetectable responses (Geyeregger, Freimuller et al. 2013). Thus by increasing 
antigen sensitivity ex-vivo, the RESTORE protocol detects antigen-reactive T-cells at frequencies which 
are closer to the in-vivo situation as compared to secondary stimulation of conventional PBMC cultures 
because they are not exaggerated by prior expansion. These features make HD preculture an ideal, 
simple and cost-effective tool for immunomonitoring of CD8 T-cell responses to infectious agents, 
vaccines and cancer-associated antigens (Lutz, Worschech et al. 2015). An impressive example of the 
latter is given in Figure 4.12D, where WT1-specific CD8 T-cell responses in leukemia patients were 
monitored up to 5 years Post-HSCT.  
Finally, it is worth mentioning that resetting of circulating T-cells to a tissue-like state before the first 
in-vitro contact with antigen avoids the loss of those antigen-specific cells which depend on pre-
sensitization for an antigen-specific response. The inclusion of these cells also in long-term expanded 
CD8 T-cell lines and clones may improve their usefulness for analytic and therapeutic purposes by 
harnessing CTL which could contribute to the effectiveness of passive cellular vaccination against 
infectious agents and tumors.  
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Experiment was repeated 3 times. ..............................................................................................43 
Figure 4.5:  HD preculture prepares T-cells to better respond to antigen, but does not increase 
the frequency of antigen-specific cells. Similar frequencies of PP65_HCMV 495-503-
specific T-cells were detected in unstimulated Fresh, HD and LD precultured PBMCs by 
flow cytometry upon pentamer staining. An HLA-A0201-restricted pentamer was used as 
a negative control. Gating was performed on viable CD8 T-cells. Experiment was 
repeated with 2 HLA-A0201 positive healthy donors. ............................................................44 
Figure 4.6:  Enhanced sensitivity of human CD8 T-cells to defined viral antigens by HD 
preculture of PBMCs. (A) IFN-γ responses of CD8 T-cells from fresh or precultured 
PBMCs from a representative healthy donor were directly compared by ELISPOT assay 
after stimulation with titrated PepMixTM Influenza A.  Unpaired t test: *** P <.0005; **** 
P <.0001; (B) Compiled data from 6 healthy donors tested as in Figure 2A. Data 
represent the mean fold-increase in IFN-γ responses of CD8 T-cells from precultured 
PBMCs relative to CD8 T-cells from fresh PBMCs after stimulation with the PepMixTM 
Influenza A. Mann-Whitney test: * P <.05; ** P <.01. Data represent median with 
interquartile range. (C) IFN-γ responses of CD8 T-cells from fresh or precultured 
PBMCs from a CMV-seropositive healthy donor after stimulation with titrated 
PP65_HCMV 495-503. (D) Compiled data from 5 donors tested as in Figure 2C. Data 
presentation as in Figure 2B. Fold increase could not be calculated for the concentrations 
0.0001 and 0.001 μg/ml where no response was detectable in fresh PBMCs. (E) CD8 T-
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cell responses in fresh and precultured PBMCs to 2 μg/ml of three different adenovirus-
derived peptides. (F) Compiled data from 7 HLA-A01 (HEX_ADE02 901-910), -A02 
(E1A_ADE02 19-27) or –A24 (HEX_ADE02 37-45) positive healthy individuals. Data 
presentation as in Figure 2B. ........................................................................................................46 
Figure 4.7:  Enhanced recall responses of HD precultured CD8 T-cells to virus-derived 
peptide pools. (A) IFN-γ ELISPOT responses of fresh or precultured PBMCs of one 
representative healthy donor to titrated amounts of the HLA-class I restricted PepMixTM 
CEF standard. (B) Response of the same donor as shown in Figure 3A to titrated 
amounts of the negative control pool PepMixTM Human Actin. Unpaired t test: * P <.05; 
** P <.005; *** P <.0005. Data represent mean ± SD for triplicate samples. (C, D) 
Identification of memory CD8 T-cells as source of for IFN-γ production by intracellular 
cytokine staining of fresh and precultured PBMCs of one representative donor that is 
different from Figure 3A, B. Results are shown as percentage of IFN-γ-positive cells 
among CD8+CD45R0+ cells and CD8+CD45R0- cells. (E) Compiled data from 22 healthy 
donors tested as in Figure 2A and presented as in Figure 2B. ...............................................47 
Figure 4.8:  Phenotyping of HD precultured PBMCs, LPMCs and TMCs. Unstimulated 
mononuclear cells (MCs) from the blood (PBMCs), lamina propria of the small intestine 
(LPMCs) or tonsils (TMCs) were stained with the given antibodies to determine their 
frequency of naïve (CD62L+ CD45R0-), effector (CD62L- CD45R0-), central memory 
(CD62L+CD45R0+) and effector memory (CD62L-CD45R0+) CD4 or CD8 T-cells 
within living MCs. Results from HD precultured PBMCs and LPMCs originate from the 
same representative obese patient without type 2 diabetes. Results from TMCs are of 
another representative tonsil and blood donor. Experiment was repeated ≥ 8 individuals.
 ..........................................................................................................................................................49 
Figure 4.9:  IFN-γ release in HD precultured PBMCs and LPMCs in response to TAB08. (A) 
Representative IFN-γ ELISPOT assay of fresh or precultured PBMCs as well as LPMCs 
of one patient with morbid obesity. Cytokine release after stimulation with 1 μg/ml 
TAB08 (previously: TGN1412) or 1 μg/ml OKT3 was assessed after 16 hours. 
Unstimulated MCs were used as negative controls. (B) IFN-γ responses to titrated 
TAB08 were detected by IFN-γ ELISPOT assays, and correlated to the frequencies of 
CD4 T-cells in MCs from blood or lamina propria as determined by flow cytometry. 
Statistical comparison of CD4 T-cell responses from LPMCs with those of fresh or HD 
precultured PBMCs. Unpaired t test: **** P ≤ 0.0001, *** P ≤ 0.0005, * P ≤ 0.05. Data 
represent mean ± SD for triplicate samples of one representative patient out of five. .....50 
Figure 4.10:  Loss of T-cell reactivity to TAB08 and SEB in LD cultures of LPMCs. LPMCs were 
either kept on ice or dispersed in suspension (1x106 cells/ ml) for 2 hours at 37 °C (5 % 
CO2) to simulate tissue exit. IFN-γ responses of T-cells to titrated amounts of TAB08 
(previously: TGN1412) and 0.25 μg/ml SEB were analyzed by an IFN-γ secretion assay 
after stimulation for 16 hours. The IFN-γ secretion assay was combined with surface 
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staining for (A) CD4 and (B) CD8 T-cells in order to determine the subtype of IFN-γ 
cells. Unpaired t test: *** P <.0005, ** P <.005. Data represent mean ± SD for triplicate 
samples of one representative patient with morbid obesity out of two. ...............................51 
Figure 4.11: Loss of virus-specific CD8 T-cell reactivity in dispersed TMCs. (A) Tonsillar 
mononuclear cells (TMCs) were prepared from uninfected fresh human tonsils and were 
either kept on ice or dispersed in suspension (1x106 cells/ ml) for 2 hours at 37 °C (5 % 
CO2) to simulate tissue exit. IFN-γ responses to titrated amounts of the HLA-class I 
restricted PepMixTM CEF standard were analyzed by an IFN-γ ELISPOT assay, and the 
frequency of CD8 memory T-cells in TMC was determined by flow cytometry. Unpaired 
t test: * P <.05. (B) Virus-specific IFN-γ responses to 0.04 or 0.4 μg/ml of the peptide 
pool were compared between CD8 memory T-cells from TMCs with those of fresh and 
HD precultured PBMCs of the same individual as presented in Figure 4A.  Similar results 
were obtained after repetition of the experiment. 2way ANOVA *** P <.0005. Data 
represent mean ± SD for triplicate samples. .............................................................................53 
Figure 4.12:  HD preculture enhances the recall responses of PBMCs to WT1-derived antigens. 
(A, B) IFN-γ T-cell responses from fresh or precultured PBMCs of one representative 
HLA-A0201 positive HSCT patient to titrated amounts of the peptide WT1_HUMAN 
126-134 or WT1_HUMAN 356-364, respectively. Unpaired t test: *** P <.0005. Data 
represent mean ± SD for triplicate samples. The experiment presented in Figure 5A was 
repeated for two different patients. (C) Compiled data from Figure 4B from 11 patients. 
Average time between stem cell transplantation and sampling: 814 days; from 166 to 2372 
days.  Data are presented as in Figure 2B. (D) Improved monitoring of anti-WT1-directed 
T-cell responses from an HLA-A0201 positive patient 4 months, 1 year and 5 years after 
HSCT upon HD preculture of PBMCs. Unpaired t test: ** P <.005; *** P <.0005; **** P 
<.0001. Data represent mean ± SD for triplicate samples. ....................................................54 
Figure 4.13:  Specificity controls of the T-cell responses presented in Figure 4.12 
(WT1_HUMAN 126-134/ HLA-A0201, WT1_HUMAN 356-364/ HLA-A0201). (A, 
B) PBMC of HIV sero-negative hematopoietic stem cell transplanted patients that show 
WT1 dependent IFN-γ releases to WT1_HUMAN 126-134 (Figure 4.12A) or 
WT1_HUMAN 356-364 (Figure 4.12B) were also treated in IFN-γ ELISPOT assays with 
titrated amounts of the irrelevant HLA-A0201-restricted peptide HIV-1 pol 476-484. (C) 
Nonspecific effects of WT1 peptide stimulation were excluded by treating PBMCs of an 
HLA-A0201 negative healthy donor with titrated WT1_HUMAN 126-134 or 356-364. 
No unspecific responses were detected. Unpaired t test: n.s.; The RESTORE effect was 
demonstrated by TAB08 responses, exclusively in HD precultured PBMCs, but not in 
fresh PBMCs of all tested patients (A, B) and healthy donors (C). Data represent mean ± 
SD for triplicate samples...............................................................................................................55 
Figure 4.14:  The RESTORE effect is independent of cryopreservation. PBMCs of a 
representative leukemia patient were frozen, thawed and tested with or without the HD 
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preculture step. IFN-γ secretion of cryroconserved and non-cryoconserved fresh or HD 
precultured samples were compared by an unpaired t test: n.s; The RESTORE effect was 
significantly analyzed by 2way ANOVA. Experiment was repeated ≥ 3 times. ..................56 
Figure 4.15:  HD preculture of PBMCs allows generation of CD8 T-cell lines with an improved 
representation of clones responding to low antigen concentrations. (A, Left) IFN-γ 
responses of CD8 T-cells from fresh or precultured PBMCs of one HLA-A0201 positive 
patient to titrated amounts of the peptide WT1_HUMAN 356-364 before expansion. 
(Right) Fresh or precultured PBMCs of the same patient were stimulated with 1 μg/ml of 
the peptide WT1_HUMAN 356-364 in a final cell density of 2x106 cells/ml and were 
expanded in the presence of IL-2, IL-7 and IL-15 for 2 weeks. After expansion, cells were 
restimulated with titrated amounts of the peptide WT1_HUMAN 356-364 or the control 
pool Human Actin in IFN-γ ELISPOT plates for 16 hours. (B, Left) IFN-γ responses of 
CD8 T-cells from fresh or precultured PBMCs of one representative healthy donor to 
titrated amounts of the HLA-class I restricted PepMixTM CEF standard and the control 
pool Human Actin before expansion. Fresh or precultured PBMCs of the same donor 
were stimulated with 0.1 μg/ml of (middle) the PepMixTM CEF standard or the PepMixTM 
Human Actin (right) and were expanded under the same conditions as presented in 
Figure 4.15A. After expansion, virus-specific CD8 T-cells were restimulated with titrated 
amounts of the PepMixTM CEF standard or the control pool Human Actin in IFN-γ 
ELISPOT plates for 16 hours, respectively. Unpaired t test: * P <.05; ** P <.005; *** P 
<.0005; **** P <.0001. Data represent mean ± SD for triplicate samples. Experiments 
were repeated 4 times. ...................................................................................................................58 
Figure 4.16:  CD137 expression on CD8 T-cells from fresh or precultured PBMCs after WT1-
specific T-cell expansion. Fresh or precultured PBMCs of the same HLA-A0201-
positive AML patient were simultaneously stimulated with 1 μg/ml of the peptide 
WT1_HUMAN 356-364 in a final cell density of 2x106 cells/ml and were expanded in the 
presence of IL-2, IL-7 and IL-15 for 2 weeks. After expansion, cells were restimulated 
with 10 μg/ml WT1_HUMAN 356-364 for 16 hours and stained for CD3, CD8 and 
CD137. Gating was performed on viable CD8 T-cells. ..........................................................59 
Figure 4.17:  HD preculture of PBMCs affects TCR signaling of CD8 T-cells. (A) Total tyrosine 
phosphorylation patterns were compared by Western blotting between freshly isolated 
CD8 T-cells and monocytes (1:1, F) and HD precultured co-cultured CD8 T-cells and 
monocytes (1:1,P) of one representative donor. After cell lysis, proteins were separated 
under reducing conditions using a 15% polyacrylamide gel. Membranes were probed with 
4G10 antibody (anti-pTyr). (B) Phosphorylation of proximal TCR signaling components 
was compared between CD8 T-cells from fresh and precultured PBMCs. Membranes 
were probed with antibodies against CD3ζ p-Y142, CD3ζ, Src p-Y394, Lck, ZAP-70 p-
Y319/ Syk p-Y352 and ZAP-70 as indicated. ERK1/2 served as a loading control. 
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Experiment was repeated ≥ 3 times with the exceptions that membranes were probed 
with antibody against ZAP-70 p-Y319/ Syk p-Y352 only once. ...........................................60 
Figure 4.18:  Gene expression analysis of CD8 memory T-cells from fresh and HD precultured 
PBMCs and tonsils. Total RNA was prepared for microarray analysis out of flow 
cytometry sorted CD8 memory T-cells (CD8+CD45R0+) from fresh (F) and HD 
precultured (P) PBMCs of three healthy individuals (1-3) and from CD8 memory T-cells 
(CD8+CD45R0+) from fresh PBMCs and TMCs (T) of three children undergoing 
tonsillectomy (4-6). (A) Agglomerative hierarchical clustering of global gene expression 
profiles. The cumulated length of vertical lines connecting two samples is indicative for 
their similarity. (B) Heatmap of differentially expressed genes showing scaled expression 
values, where dark blue corresponds to the lowest expression and dark red to the highest 
expression level. .............................................................................................................................62 
Figure 4.19:  Comparison of the expression profile of CD8 memory T-cells from HD 
precultured PBMCs and TMCs. (A) Radar plot displaying gene set enrichment results 
from CD8 memory T-cells (CD8+CD45R0+) from HD precultured PBMCs versus fresh 
PBMCs (dark grey area) and those from TMCs versus fresh PBMCs (light grey area). Of 
the 13 functional clusters / pathways shown, each displayed a globally significant (false 
discovery rate [FDR] <.05) enrichment in at least one comparison. Enrichment FDRs 
were transformed to –log10 (FDR) and displayed along the axis for each pathway; FDR 
<.05 corresponds to –log10 (FDR) >1.3. (B) Heatmap of genes that display concordant 
expression changes between CD8 memory T-cells (CD8+CD45R0+) from HD 
precultured PBMCs and from TMCs relative to fresh PBMCs. ............................................63 
Figure 4.20:  HD preculture of PBMCs affects metabolism of CD8 memory T-cells. 
Differentially expressed glycolysis pathway genes from a comparison of CD8 memory T-
cells (CD8+CD45R0+) from fresh and HD precultured PBMCs are shown (A) in a 
heatmap of scaled expression values and (B) in a KEGG pathway map with color coded 
log fold changes. (C) Venn Diagram indicating high concordance of changes in glycolysis-
related gene expression changes between CD8 memory T-cells (CD8+CD45R0+) from 
fresh PBMCs (presented in 7A and 7B) and pan T-cells from LD precultured PBMCs. ..64 
Figure 4.21:  GLUT1 expression in CD8 memory T-cells from fresh and HD precultured 
PBMCs. Unstimulated fresh (F) and HD precultured (P) PBMCs were stained for the 
glucose transporter 1 (GLUT1). Expression values are given as ΔMFI: MFI (GLUT1) – 
MFI (Isotype control). Gating was performed on viable CD8 memory T-cells 
(CD8+CD45R0+). (A) HD precultured PBMCs were additionally stimulated with 1 µg/ 
ml TAB08. (B) PBMCs were additionally precultured at a low cell density (LD). ..............66 
Figure 4.22:  Actin cell adhesion and mobility of CD8 memory T-cells. Color-coded log FC of 
differentially expressed leukocyte transendothelial migration pathway genes from the 
comparison of CD8 memory T-cells (CD8+CD45R0+) from fresh and HD precultured 
PBMCs are shown in a KEGG pathway map. .........................................................................67 
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Figure 4.23:  Integrin expression of CD8 memory T-cells from fresh and precultured PBMCs. 
Unstimulated fresh (F) and HD precultured (P) PBMCs of one representative healthy 
donor were surface stained to detect the expression of the integrins CD11b, CD18, 
CD49d, CD29, and CD11a within CD8 memory T-cells (CD8+CD45R0+). Isotype 
stainings (Iso) were used as controls. Mean fluorescence intensities (MFI) are given for 
each staining (left column) and Δ MFI were calculated: MFI (Integrin) – MFI (Isotype); 
(right column). Staining was repeated ≥ 3 times with similar results. ...................................68 
Figure 5.1:  Metabolic reprogramming in T-cells controls T-cell functionality. Resting T-cells 
metabolize glucose to pyruvate, which enters the mitochondrial citrate cycle and 
generates reducing equivalents for fueling ATP production via OXPHOS. Activated T 
cells engage glycolysis, where pyruvate is fermented to lactate in the cytoplasm even when 
sufficient oxygen is present to utilize OXPHOS (Warburg effect, aerobic glycolysis). 
Although both processes generate ATP, glycolysis is less efficient in producing ATP, 
indicating that it might provide other advantages such as uptake and incorporation of 
nutrients into the biomass needed for cellular proliferation. Beside T-cell proliferation, 
aerobic glycolysis regulates cytokine production. The key glycolytic enzyme 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) controls effector cytokine 
production on a translational level. (Chang, Curtis et al. 2013) © Cell Press ......................73 
Figure 5.2:  Maturation events in blood-derived T-cells and monocytes during HD preculture. 
During HD preculture of PBMCs, monocytes improve their features as accessory cells by 
an enhanced expression of HLA molecules and the co-stimulatory ligand CD86. T-cells 
frequently interact with matured monocytes by scanning of MHC molecules that are 
loaded with self-peptide. Frequent TCR engagement and co-stimulation (CD28-CD86) 
results in tonic TCR signaling indicated by an enhanced tyrosine phosphorylation of the 
CD3 ζ chains and Lck. The primed TCR signaling machinery of “restored” T-cells in 
combination with increased glycolysis and lactic acid fermentation (referred to as 
Warburg effect or aerobic glycolysis) which was observed only on the RNA level, but was 
not on the cellular level until now, lowers the threshold for full T-cell activation. ............75 
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